Sleep disorders (combined)

SLEEP

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints F5_SLEEP G6_SLEEPAPNO G6_NARCOCATA G6_SLEEPDISOTH	111792
6. Filter based on genotype QC (FinnGen only)	107907

Control definitions (FinnGen only)

Control exclude: F5_BEHAVE

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	SLEEP
CONTROL_EXCLUDE	F5_BEHAVE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_SLEEP\|G6_SLEEPAPNO\|G6_NARCOCATA\|G6_SLEEPDISOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sleep disorders (combined) based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	107907	59593	48314
Unadjusted period prevalence (%)	21.58	21.14	22.13
Median age at first event (years)	54.77	53.94	55.80

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
73853: Matched controls
387493

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R03BA01

ATC

beclometasone; inhalant

1.7

323.0

8302

27538

SPAT1301

SPAT

No procedures

1.4

322.5

19604

78397

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

321.0

22920

94283

M01AH01

ATC

celecoxib; oral

1.6

320.3

10146

35445

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

319.4

14844

56377

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.2

319.4

1549

2544

SXC06

NOMESCO Finland

Clinical work to produce sleep apnoea splint

26.8

319.3

361

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.8

319.3

6064

18464

D01

ICPC

Abdominal pain/cramps general

1.7

319.0

7524

24383

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

317.4

8442

28241

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

316.9

33305

145851

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

314.2

12394

45477

ZXC60

NOMESCO Finland

Application of heat

4.3

313.9

1042

1285

R00.2

ICD-10 Finland

Palpitations

1.9

312.9

4787

13594

ZY010

NOMESCO Finland

Hospital outpatient

2.2

312.4

3260

8014

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

312.1

13081

48608

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

311.4

7360

23855

DJD20

NOMESCO Finland

Plastic repair of septum of nose

2.6

309.4

2151

4369

M02AA07

ATC

piroxicam; topical

1.4

309.3

20591

83553

F43.8

ICD-10 Finland

Other reactions to severe stress

2.9

309.0

1748

3162

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

308.4

5806

17622

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

308.1

6667

21081

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

307.7

6034

17497

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.1

307.7

7037

18628

N02BF01

ATC

gabapentin; oral

2.1

307.7

5014

12920

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.0

307.7

2347

4129

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

307.7

15868

54699

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

307.7

16701

63073

C10AA07

ATC

rosuvastatin; oral

1.5

307.7

18092

68745

E66.01

ICD-10 Finland

Obesity due to excess calories

4.1

307.7

8326

11720

Z71.8

ICD-10 Finland

Other specified counselling

1.6

307.7

20703

77374

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.0

307.7

9027

17191

WX723

NOMESCO Finland

CPAP therapy

557.0

307.7

5594

N06AX05

ATC

trazodone; oral

5.1

307.7

2045

2155

N06AA12

ATC

doxepin; systemic

2.6

307.7

3044

6278

F51.0

ICD-10 Finland

Nonorganic insomnia

+∞

307.7

34973

N03AE01

ATC

clonazepam; systemic

2.2

307.7

3366

8100

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.0

307.7

11392

22420

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.9

307.7

4231

7822

A02BC05

ATC

esomeprazole; systemic

1.7

307.7

27132

99385

E66

ICD-10 Finland

Obesity

3.6

307.7

4081

6143

R03AC02

ATC

salbutamol; inhalant

2.0

307.7

40961

150104

R05

ICPC

Cough

1.6

307.7

15672

55366

N06AB04

ATC

citalopram; systemic

2.3

307.7

15363

40323

R03BA02

ATC

budesonide; inhalant

1.6

307.7

11154

38333

N06AX03

ATC

mianserin; oral

3.1

307.7

3191

5548

WX780

NOMESCO Finland

Remote monitoring CPAP

2160.5

307.7

6049

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

307.7

37944

147257

R52.9

ICD-10 Finland

Pain, unspecified

1.8

307.7

6049

18095

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

307.7

38318

156285

J02AC01

ATC

fluconazole; systemic

1.5

307.7

25148

100387

R03AK08

ATC

formoterol and beclometasone; inhalant

2.4

307.7

2714

5970

ENC30

NOMESCO Finland

Plastic operation of pharynx

6.6

307.7

941

751

R02

ICPC

Shortness of breath/dyspnoea

2.0

307.7

8795

24044

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.3

307.7

4487

7499

N05AX12

ATC

aripiprazole; systemic

2.5

307.7

2705

5770

H02AB06

ATC

prednisolone; systemic

1.6

307.7

31660

123640

SPAT1051

SPAT

Guidance regarding sleep disorders

8.4

307.7

1516

967

S18

ICPC

Laceration/cut

1.5

307.7

29309

116112

R60.0

ICD-10 Finland

Localized oedema

1.8

307.7

7181

21750

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

307.7

2796

6048

WX290

NOMESCO Finland

Other blockage of nerve

1.5

307.7

32099

132778

J01CA04

ATC

amoxicillin; systemic

1.6

307.7

58179

269975

M01AC06

ATC

meloxicam; systemic, rectal

1.5

307.7

21709

84968

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

307.7

35492

148966

Z3231

NOMESCO Finland

Registered nurse

1.5

307.7

16730

63725

J01DA01

ATC

[U] cefalexin

1.4

307.7

40443

179433

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.7

307.7

1889

2761

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

307.7

46593

212665

C07AA05

ATC

propranolol; systemic

1.9

307.7

14271

43771

SFA30

NOMESCO Finland

Three-surface restoration

1.5

307.7

26623

107920

R03BA05

ATC

fluticasone; inhalant

1.6

307.7

11617

39918

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

307.7

3668

6083

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

307.7

18009

64402

UJF32

NOMESCO Finland

Coloscopy

1.5

307.7

15437

56984

SPAT1283

SPAT

Restricted health certificate

1.6

307.7

11965

42291

R01AD58

ATC

fluticasone, combinations; nasal

1.8

307.7

17574

57000

M54.5

ICD-10 Finland

Low back pain

2.0

307.7

26575

86583

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

307.7

5402

14347

R99

ICPC

Respiratory disease other

4.4

307.7

1272

1529

P74

ICPC

Anxiety disorder/anxiety state

2.6

307.7

3082

6347

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.3

307.7

3613

5862

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

11.7

307.7

841

380

J45

ICD-10 Finland

Asthma

2.0

307.7

6748

18804

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

307.7

26001

93148

SPAT1310

SPAT

Counselling related to known health issue

1.6

307.7

21245

79304

J01FA09

ATC

clarithromycin; systemic

1.4

307.7

19368

76893

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

307.7

7717

22855

L08

ICPC

Shoulder symptom/complaint

1.6

307.7

13332

45944

E66.00

ICD-10 Finland

Metabolic syndrome

3.8

307.7

4270

6125

C03CA01

ATC

furosemide; systemic

1.5

307.7

16187

60578

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

307.7

28937

111166

A10BA02

ATC

metformin; oral

1.7

307.7

17315

57751

L17

ICPC

Foot/toe symptom/complaint

1.7

307.7

19026

66162

M01AE02

ATC

naproxen; oral, rectal

1.6

307.7

38980

161521

N06AA09

ATC

amitriptyline; systemic

2.2

307.7

5863

14711

R96

ICPC

Asthma

1.9

307.7

5781

16775

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.8

307.7

6724

20463

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

307.7

16904

54809

SPAT1312

SPAT

General health counselling

1.5

307.7

20977

82628

A02BC01

ATC

omeprazole; systemic

1.5

307.7

16639

62256

R42

ICD-10 Finland

Dizziness and giddiness

1.7

307.7

14338

48634

G47.9

ICD-10 Finland

Sleep disorder, unspecified

10.5

307.7

2963

1539

P02

ICPC

Acute stress reaction

2.5

307.7

3772

8043

SFA10

NOMESCO Finland

One-surface restoration

1.5

307.7

37772

159286

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

5.0

307.7

1117

1181

P29

ICPC

Psychological sympt/compl other

2.4

307.7

5221

12074

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.6

307.7

2428

3668

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

307.7

16763

57041

M01AB05

ATC

diclofenac; systemic, rectal

1.6

307.7

45012

189473

ENC40

NOMESCO Finland

Uvulopalatopharyngoplasty

10.3

307.7

816

420

P01

ICPC

Feeling anxious/nervous/tense

2.3

307.7

10086

24511

N06AX12

ATC

bupropion; oral

3.2

307.7

6061

10448

AA40B, ,

NOMESCO Finland

95.4

307.7

452

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

307.7

13110

37414

C09CA06

ATC

candesartan; oral

1.6

307.7

14486

50982

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

307.7

13403

46628

M79.1

ICD-10 Finland

Myalgia

1.9

307.7

9592

28850

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

307.7

3677

9246

L03

ICPC

Low back symptom/complaint

1.8

307.7

19500

63570

C08CA13

ATC

lercanidipine; oral

1.7

307.7

7767

25260

C07AB07

ATC

bisoprolol; oral

1.6

307.7

29791

114739

R01AD09

ATC

mometasone; nasal

1.9

307.7

33417

118975

H03AA01

ATC

levothyroxine sodium; systemic

1.5

307.7

13822

50654

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

4.2

307.7

3075

3988

N05AH04

ATC

quetiapine; oral

3.5

307.7

16873

30347

A04

ICPC

Weakness/tiredness general

1.8

307.7

10100

30596

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

307.7

5641

16657

G04BD12

ATC

mirabegron; oral

1.8

307.7

6515

19465

T82

ICPC

Obesity

4.3

307.7

3379

4258

N05CF02

ATC

zolpidem; oral

3.0

307.7

14707

30076

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

307.7

12197

41736

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

307.7

15426

48976

J01FA10

ATC

azithromycin; systemic

1.5

307.7

39615

169434

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

307.7

12284

38645

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

307.7

15024

54456

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

307.7

13918

45722

SPAT1263

SPAT

Sampling

1.5

307.7

28602

113037

N06AB10

ATC

escitalopram; oral

2.5

307.7

17504

42410

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

307.7

8412

27065

J01AA02

ATC

doxycycline; systemic

1.7

307.7

53025

232016

T90

ICPC

Diabetes non-insulin dependent

1.8

307.7

14355

45829

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

307.7

18439

63466

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

9.8

307.7

15383

10176

J20

ICD-10 Finland

Acute bronchitis

1.8

307.7

6289

18897

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

307.7

7911

23070

DHB50

NOMESCO Finland

Turbinoplasty

3.3

307.7

1744

2829

K02.1

ICD-10 Finland

Caries of dentine

1.5

307.7

41092

175751

R03BB04

ATC

tiotropium bromide; inhalant

1.9

307.7

5635

16231

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

307.7

17502

61844

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

307.7

32032

129806

SPAT1094

SPAT

Continuous Positive Airway Pressure

69.9

307.7

1129

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

307.7

25901

106500

N06AB03

ATC

fluoxetine; oral

2.4

307.7

8773

20602

N03AX12

ATC

[U] gabapentin; oral

2.0

307.7

10704

30741

A10BJ02

ATC

liraglutide; parenteral

4.3

307.7

1993

2464

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

+∞

307.7

1484

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.0

307.7

8519

16321

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.0

307.7

5222

9692

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

307.7

425

E66.9

ICD-10 Finland

Obesity, unspecified

4.1

307.7

2807

3720

M54

ICD-10 Finland

Dorsalgia

1.9

307.7

8320

24773

R74

ICPC

Upper respiratory infection acute

1.6

307.7

22527

83632

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

307.7

7412

22388

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

307.7

18123

66627

D07AC01

ATC

betamethasone; topical

1.4

307.7

22251

90180

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.2

307.7

1880

3144

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

307.7

7272

17180

M01AH05

ATC

etoricoxib; oral

1.7

307.7

42782

171189

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

307.7

15310

49366

C10AA05

ATC

atorvastatin; oral

1.5

307.7

23763

94299

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

307.7

12842

45970

F43.0

ICD-10 Finland

Acute stress reaction

2.8

307.7

4081

7877

160

Kela drug reimbursment

exenatide

4.1

307.7

1150

1497

P76

ICPC

Depressive disorder

2.8

307.7

5166

10230

M79.7

ICD-10 Finland

Fibromyalgia

3.0

307.7

2266

4107

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

307.7

17660

68622

N06AX11

ATC

mirtazapine; oral

4.0

307.7

33573

66739

G44.2

ICD-10 Finland

Tension-type headache

2.0

307.7

9507

26736

R04

ICPC

Breathing problem other

3.3

307.7

2633

4356

SFA20

NOMESCO Finland

Two-surface restoration

1.5

307.7

40144

170306

L28

ICPC

Limited function/disability (L)

1.7

307.7

10040

33610

SPAT1377

SPAT

Polysomnography

8.4

307.7

3269

2114

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

307.7

20045

74180

F33

ICD-10 Finland

Recurrent depressive disorder

3.8

307.7

1704

2386

N05BA04

ATC

oxazepam; oral

2.5

307.7

20854

53054

J34.2

ICD-10 Finland

Deviated nasal septum

2.6

307.7

3472

7103

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

307.7

7675

22635

Z73.0

ICD-10 Finland

Burn-out

3.5

307.7

2938

4511

D82

ICPC

Teeth/gum disease

1.4

307.7

24171

99205

R5140

NOMESCO Finland

Monitoring the use of the aid

24.6

307.7

15742

4223

P01AB01

ATC

metronidazole; oral, rectal

1.5

307.7

25577

101839

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

+∞

307.7

3360

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

307.7

8703

26031

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

307.7

36560

139829

N05CD07

ATC

temazepam; oral

2.1

307.7

6861

18429

SPAT1240

SPAT

Therapeutic discussion

2.3

307.7

8237

20331

K30

ICD-10 Finland

Functional dyspepsia

1.7

307.7

6801

21262

R01AD12

ATC

fluticasone furoate; nasal

1.8

307.7

22859

77176

N06AA06

ATC

trimipramine; systemic

3.7

307.7

1552

2229

M03BX02

ATC

tizanidine; oral

1.8

307.7

44226

174506

SPAT1260

SPAT

Consultation of another employee

1.6

307.7

10958

38505

N05BA01

ATC

diazepam; systemic, rectal

1.9

307.7

8086

23407

A10BJ06

ATC

semaglutide; parenteral

3.4

307.7

3290

5305

R01AD08

ATC

fluticasone; nasal

1.7

307.7

19460

67723

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

307.7

11998

41491

XA421

NOMESCO Finland

Nocturnal polygraphy

18.9

307.7

454

127

R21

ICPC

Throat symptom/complaint

1.5

307.7

14414

53656

N02BF02

ATC

pregabalin; oral

2.3

307.7

3594

8612

D11

ICPC

Diarrhoea

1.8

307.7

7975

24090

E0000UV, ,

ATC

1.4

307.7

26839

112076

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

307.7

50498

220668

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

307.7

9104

27490

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.7

307.7

2621

5299

A02BC02

ATC

pantoprazole; systemic

1.8

307.7

47304

191173

OAB93, ,

SPAT

2.7

307.7

4244

8543

N03AX09

ATC

lamotrigine; oral

2.6

307.7

3276

6877

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.6

307.7

3433

5227

N06AX26

ATC

vortioxetine; oral

3.2

307.7

6225

10930

R06AX27

ATC

desloratadine; oral

1.5

307.7

18911

71418

N02BE01

ATC

paracetamol; systemic, rectal

2.2

307.7

64361

291020

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

307.7

3052

6360

R53

ICD-10 Finland

Malaise and fatigue

2.1

307.7

18295

51862

R03BA08

ATC

ciclesonide; inhalant

2.0

307.7

5404

15031

R05

ICD-10 Finland

Cough

1.7

307.7

13741

46179

N06AX16

ATC

venlafaxine; oral

2.8

307.7

11896

24585

F34.1

ICD-10 Finland

Dysthymia

3.1

307.7

2545

4352

E66.8

ICD-10 Finland

Other obesity

4.6

307.7

4933

5955

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

307.7

47060

206978

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

307.7

5710

16888

L13

ICPC

Hip symptom/complaint

1.6

307.7

10316

35508

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

307.7

30471

106472

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

30180

103036

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

307.7

64063

306795

R06.0

ICD-10 Finland

Dyspnoea

2.1

307.7

19207

55044

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

307.7

16014

51338

A98

ICPC

Health maint/preventive medicine

2.6

307.7

71020

351099

N05BA12

ATC

alprazolam; oral

2.2

307.7

6404

16348

M25.5

ICD-10 Finland

Pain in joint

1.8

307.7

21956

74962

N02AX02

ATC

tramadol; systemic, rectal

1.8

307.7

29269

104711

N06AB06

ATC

sertraline; oral

2.5

307.7

8782

19793

R03DC03

ATC

montelukast; oral

1.8

307.7

10892

33894

R06.5

ICD-10 Finland

Mouth breathing

6.5

307.7

9557

8678

XG466

NOMESCO Finland

Sleep oxymetry

13.7

307.7

3246

1295

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

307.7

11426

36736

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

307.7

6028

17468

XA420

NOMESCO Finland

Extensive sleep examination

24.4

307.7

1015

221

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

307.7

25664

104101

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

307.7

11912

35972

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

307.7

14896

49324

C09CA01

ATC

losartan; oral

1.5

307.7

14290

52663

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

307.7

8022

26190

N06AB05

ATC

paroxetine; oral

2.4

307.7

3899

8706

N06AX22

ATC

agomelatine; oral

4.3

307.7

1839

2288

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.8

307.7

3334

6492

L01

ICPC

Neck symptom/complaint

1.8

307.7

10093

32000

OAA65, ,

SPAT

2.1

307.7

12174

33094

N03AX16

ATC

[U] pregabalin

1.9

307.7

15749

47315

J01FF01

ATC

clindamycin; systemic

1.5

307.7

16520

63686

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.7

307.7

7764

24554

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

7.5

307.7

2164

1546

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.6

307.7

1559

2277

AA1AD

NOMESCO Finland

CT of head and brain

1.5

307.7

15769

58753

L15

ICPC

Knee symptom/complaint

1.7

307.7

15242

51997

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

307.7

15573

55030

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

307.7

26251

104167

A10BK03

ATC

empagliflozin; oral

2.0

307.7

5439

14497

F32

ICD-10 Finland

Depressive episode

3.1

307.7

4413

7800

J01FA06

ATC

roxithromycin; oral

1.4

307.7

24619

99716

SPAT1262

SPAT

Handing over of treatment supplies

1.7

307.7

10396

33999

Z01.2

ICD-10 Finland

Dental examination

1.5

307.7

30792

126498

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

307.7

18459

59927

R06AE07

ATC

cetirizine; oral

1.5

307.7

29628

120043

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

307.7

13734

45207

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

307.7

22090

88143

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

307.7

27349

109161

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

307.7

6827

13773

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

307.7

7306

23138

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

307.7

12329

41106

F32.1

ICD-10 Finland

Moderate depressive episode

3.1

307.7

4875

8640

OAB91, ,

SPAT

2.1

307.7

3983

10371

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

307.7

4351

11794

WX722

NOMESCO Finland

PEEP

14.7

307.7

5046

1926

R51.80

ICD-10 Finland

Headache

2.0

307.7

11122

31975

G47.3

ICD-10 Finland

Sleep apnoea

82.0

307.7

41070

5831

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.9

307.7

2203

4061

KMAK, ,

NOMESCO Finland

1.4

307.7

33947

146184

N06BA04

ATC

methylphenidate; oral

2.7

307.7

2344

4593

N06AX21

ATC

duloxetine; oral

2.8

307.7

9283

18824

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

307.7

29497

112209

N05AH03

ATC

olanzapine; systemic

2.2

307.7

3965

9954

J01DB01

ATC

cefalexin; oral

1.9

307.7

59594

268421

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

307.7

19735

77950

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

307.7

10068

34610

R07.3

ICD-10 Finland

Other chest pain

1.8

307.7

6024

18084

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.3

307.7

6529

15977

OAB43, ,

SPAT

1.5

307.7

19021

74364

A02BC03

ATC

lansoprazole; oral

1.6

307.7

17246

63407

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

307.7

15571

53396

N04BC05

ATC

pramipexole; oral

2.5

307.7

4924

10596

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.9

307.7

2127

3901

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

307.7

3954

6551

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

307.7

30778

113769

F50.9

ICD-10 Finland

Eating disorder, unspecified

17.0

307.7

509

158

F51

ICD-10 Finland

Nonorganic sleep disorders

4.4

307.7

3733

4609

P03

ICPC

Feeling depressed

2.5

307.7

8229

18403

N01

ICPC

Headache

1.7

307.7

7468

24013

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.4

307.7

3263

7356

P06

ICPC

Sleep disturbance

7.0

307.7

14610

13181

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

307.7

51626

223470

N05CF01

ATC

zopiclone; oral

2.6

307.7

25427

65212

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.5

307.7

2827

6081

C08CA01

ATC

amlodipine; oral

1.6

307.7

22201

83804

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.9

307.5

1809

3349

SDA03

NOMESCO Finland

Periodontal treatment

1.4

307.4

25369

106715

A01

ICPC

Pain general/multiple sites

1.8

306.9

5379

15966

SPAT1058

SPAT

PEF monitoring instruction

1.9

305.8

4768

13623

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

304.6

1802

3347

R29

ICPC

Respiratory symptom/complaint other

2.0

303.4

4108

11172

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

94.1

302.6

286

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

302.6

8083

27046

-1, ,

NOMESCO Finland

1.4

301.1

21573

88558

R51

ICD-10 Finland

Headache

2.1

300.3

3598

9347

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

299.5

5474

16457

SPAT1153

SPAT

Removal of sutures

1.4

299.4

18432

73677

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

298.1

14156

53886

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.8

297.9

1802

3390

G43.9

ICD-10 Finland

Migraine, unspecified

2.0

296.6

3844

10286

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

296.5

9136

31656

F50.2

ICD-10 Finland

Bulimia nervosa

25.0

296.3

341

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

296.1

8427

28639

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

3.4

295.6

1346

2118

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

31.4

295.2

322

A02BA02

ATC

ranitidine; systemic

1.5

294.7

10498

37611

GX2D5

NOMESCO Finland

Sleep oximetry

9.8

292.6

487

261

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

291.0

5437

16450

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

8.7

290.8

522

317

S29

ICPC

Skin symptom/complaint other

1.5

288.1

11397

41755

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

287.3

4838

14166

L02

ICPC

Back symptom/complaint

1.7

285.4

6178

19514

N06AG02

ATC

moclobemide; oral

2.4

284.6

2460

5563

4471

FHL

Pharyngoplasty

19.0

283.3

353

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

283.0

3283

8417

L16

ICPC

Ankle symptom/complaint

1.7

282.1

6915

22597

A10BK01

ATC

dapagliflozin; oral

2.0

281.4

3812

10362

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

280.6

4238

11967

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

280.5

4656

13567

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

279.4

3189

8123

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.9

279.4

1658

3084

F32.0

ICD-10 Finland

Mild depressive episode

2.7

279.1

1821

3573

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

278.6

1951

3976

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

9.9

276.7

458

243

R01AD01

ATC

beclometasone; nasal

1.6

275.2

8843

30900

R35

ICD-10 Finland

Polyuria

2.0

273.6

3736

10181

3051, ,

Kela drug reimbursment

5.7

273.1

672

618

M48.0

ICD-10 Finland

Spinal stenosis

1.7

272.0

6479

20998

A10BJ05

ATC

dulaglutide; parenteral

3.6

271.5

1138

1688

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

271.0

12539

47367

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

270.5

21254

88221

N05AA02

ATC

levomepromazine; systemic

2.4

269.3

2249

5003

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

269.0

13473

51677

A03

ICPC

Fever

1.5

268.7

10907

40113

SPAT1097

SPAT

Recording of ECG

1.6

268.4

8026

27559

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

268.0

23920

101269

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

266.6

2049

4378

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

266.2

17807

71930

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

265.9

10831

39853

M54.2

ICD-10 Finland

Cervicalgia

1.8

265.6

4587

13529

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

264.6

15486

61105

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.7

261.9

1769

3536

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

259.4

5111

15691

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

258.7

8177

28432

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

258.6

4903

14879

ZXE00

NOMESCO Finland

One hour or less

1.3

258.0

23611

100190

SBB10

NOMESCO Finland

Dental impressions

1.9

257.0

4214

12219

R03AC03

ATC

terbutaline; inhalant

1.6

256.3

8151

28376

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

256.0

7743

26639

J01MA02

ATC

ciprofloxacin; systemic

1.3

255.8

22973

97172

R4110, ,

SPAT

1.8

253.7

4728

14271

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.4

253.4

1146

1794

L12

ICPC

Hand/finger symptom/complaint

1.5

253.3

9677

35093

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.6

252.6

1761

3579

N17

ICPC

Vertigo/dizziness

1.6

252.4

6914

23211

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

252.1

11543

43441

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.5

252.0

1908

4045

A46

ICD-10 Finland

Erysipelas

1.6

252.0

7949

27613

EBA00

NOMESCO Finland

Extraction of tooth

1.3

251.5

22585

95468

A11

ICPC

Chest pain NOS

1.8

251.1

4530

13536

R06AX22

ATC

ebastine; oral

1.5

251.0

10119

37107

WX723, ,

SPAT

9.7

250.8

421

229

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.8

250.5

1512

2839

N05BE01

ATC

buspirone; oral

2.7

250.4

1705

3422

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.6

249.8

1774

3640

SGA01

NOMESCO Finland

Emergency treatment

1.5

249.4

9924

36287

C03DA01

ATC

spironolactone; oral

1.7

249.2

6317

20787

C10AA01

ATC

simvastatin; oral

1.3

249.0

22250

93946

A10BH01

ATC

sitagliptin; oral

1.8

248.7

4915

15095

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

247.1

6690

22387

M01AX17

ATC

nimesulide; oral

1.4

247.0

12837

49473

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

246.8

20789

86953

A10BX07

ATC

[U] liraglutide

4.7

246.4

741

836

A02BC04

ATC

rabeprazole; oral

1.7

244.9

4926

15205

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

244.6

3152

8402

R83

ICPC

Respiratory infection other

1.4

240.9

16584

67109

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.9

238.4

1403

2596

Z01.7

ICD-10 Finland

Laboratory examination

1.5

237.0

8504

30385

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

236.6

24771

106855

C10AX09

ATC

ezetimibe; oral

1.5

235.5

8031

28369

Z05

ICPC

Work problem

2.5

234.8

1773

3753

R12

ICD-10 Finland

Heartburn

1.7

234.6

4706

14508

R52.2

ICD-10 Finland

Other chronic pain

2.3

233.5

2095

4814

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

233.0

5268

16798

F43

ICD-10 Finland

Reaction to severe stress, and adjustment disorders

2.9

232.9

1334

2429

F50.0

ICD-10 Finland

Anorexia nervosa

35.3

232.7

248

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

232.7

5227

16638

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

232.1

12081

46507

OAB72

NOMESCO Finland

Weight control and weight loss guidance

5.8

231.9

564

512

OAA81, ,

SPAT

2.4

231.8

1885

4137

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

231.5

5053

15955

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

231.5

21582

91461

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

230.6

4294

12944

M01AX05

ATC

glucosamine; oral

1.5

230.1

9824

36389

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

229.5

15137

60733

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

229.4

6439

21719

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.7

229.0

1548

3094

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

228.9

8230

29401

P25

ICPC

Phase of life problem adult

2.1

228.4

2630

6713

B01AB05

ATC

enoxaparin; parenteral

1.4

226.8

17855

73695

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.6

225.6

1570

3187

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

225.4

3729

10830

Z00.0

ICD-10 Finland

General medical examination

1.4

225.1

11536

44249

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.1

223.3

1158

1984

XF402

NOMESCO Finland

ECG with work load test

1.7

222.4

5490

17914

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

222.4

4188

12664

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

221.5

12256

47657

7849C

ICD-9 Finland

Symptoms involving head and neck, Other symptoms involving head and neck[KUORSAUS]

5.7

221.5

552

515

205

Kela drug reimbursment

Chronic hypertension

1.4

220.6

13513

53490

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.4

220.1

16884

69345

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

219.9

7253

25402

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.1

219.7

1159

2007

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

219.5

1054

1718

U02

ICPC

Urinary frequency/urgency

1.5

218.7

8032

28806

G43

ICD-10 Finland

Migraine

1.9

218.5

3196

8907

S06.0

ICD-10 Finland

Concussion

1.6

218.4

6343

21560

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

217.9

3442

9844

N03AG01

ATC

valproic acid; systemic, rectal

1.9

217.1

3378

9612

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

217.1

3405

9715

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

214.5

2648

6941

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

213.2

11259

43377

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

212.7

17648

73295

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

212.5

3546

10322

C09DA01

ATC

losartan and diuretics; oral

1.6

212.4

5478

18070

R11

ICD-10 Finland

Nausea and vomiting

1.7

211.1

4975

16027

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.4

210.8

11421

44196

N07BB01

ATC

disulfiram; oral

2.1

210.4

2376

6016

N30.0

ICD-10 Finland

Acute cystitis

1.5

210.3

9402

35088

H01

ICPC

Ear pain/earache

1.5

210.3

7040

24722

162

Kela drug reimbursment

liraglutide

4.6

210.1

641

733

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

209.8

2969

8177

207

Kela drug reimbursment

Chronic arrhythmias

1.5

209.3

7691

27566

GD1AA, ,

SPAT

1.6

209.1

6870

24020

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

209.0

3667

10845

D07AC13

ATC

mometasone; topical

1.3

208.8

16865

69717

F41

ICD-10 Finland

Other anxiety disorders

3.0

208.6

1112

1938

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.5

208.3

889

1336

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

208.0

3513

10264

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

207.9

2250

5600

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.7

206.4

4391

13749

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

206.3

11063

42712

UKC02

NOMESCO Finland

Cystoscopy

1.5

205.5

8314

30399

SPAT1254

SPAT

Administration of medicine

1.5

205.5

8680

32019

T83

ICPC

Overweight

2.8

204.9

1272

2426

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

204.8

4320

13494

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.9

204.0

1169

2129

WX002

NOMESCO Finland

Sedation and analgesia

1.4

203.9

10546

40441

M04AA01

ATC

allopurinol; systemic

1.6

203.8

6415

22202

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

203.6

5940

20194

H02AB04

ATC

methylprednisolone; systemic

1.5

202.5

7934

28811

P99

ICPC

Psychological disorders other

2.4

202.3

1748

3946

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

202.1

5227

17245

F50.3

ICD-10 Finland

Atypical bulimia nervosa

20.1

199.5

244

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.8

198.1

1215

2301

K08.80

ICD-10 Finland

Toothache NOS

1.6

198.1

5141

16973

RK320, ,

NOMESCO Finland

5.4

197.7

514

502

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.8

197.1

1201

2266

K04.0

ICD-10 Finland

Pulpitis

1.6

197.1

5542

18665

J01MA12

ATC

levofloxacin; systemic

1.4

197.0

9956

37992

SPAT1211

SPAT

Application of soft bandage

1.6

196.9

5009

16451

M02AA10

ATC

ketoprofen; topical

1.5

196.4

8558

31741

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

196.3

5230

17379

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.4

196.3

1565

3401

A99

ICPC

Disease/condition unspecnature/site

1.6

195.9

5131

16976

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

194.9

3089

8838

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

194.7

1505

3221

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

194.4

6939

24688

Z2445

NOMESCO Finland

Psychologist

2.1

194.0

2294

5912

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

193.1

4078

12735

RK323, ,

NOMESCO Finland

18.9

192.3

240

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

192.1

14889

61028

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

190.3

4568

14772

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.4

190.1

12723

50940

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

190.1

5458

18469

F50.8

ICD-10 Finland

Other eating disorders

17.5

189.9

243

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.7

189.4

4133

13024

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

189.3

12362

49292

D19

ICPC

Teeth/gum symptom/complaint

1.3

189.0

17114

71764

D06

ICPC

Abdominal pain localized other

1.6

188.5

5029

16711

IHZ05, ,

SPAT

2.0

188.2

2362

6225

F43.00

ICD-10 Finland

Acute stress reaction mild

2.4

188.0

1499

3257

R06.2

ICD-10 Finland

Wheezing

2.0

187.6

2490

6699

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.8

187.6

1170

2237

M10.9

ICD-10 Finland

Gout, unspecified

1.8

187.1

3353

9973

H02

ICPC

Hearing complaint

1.5

186.3

7036

25324

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

185.8

3978

12466

K80

ICPC

Cardiac arrhythmia NOS

1.7

185.8

4269

13642

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

185.7

3190

9363

F50.1

ICD-10 Finland

Atypical anorexia nervosa

22.3

185.5

220

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

185.4

7266

26353

R06AE09

ATC

levocetirizine; oral

1.5

185.3

8331

31061

D07AD01

ATC

clobetasol; topical

1.4

185.2

9105

34530

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

185.1

12413

49689

OAB50, ,

SPAT

1.9

183.1

2883

8227

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

4.1

183.0

638

820

D10

ICPC

Vomiting

1.7

183.0

3690

11367

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

182.5

4303

13844

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

253.2

182.4

241

C07AB02

ATC

metoprolol; systemic

1.4

182.3

10164

39424

C02AC05

ATC

moxonidine; oral

2.0

182.1

2273

5978

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.0

182.0

992

1753

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

181.9

5983

20888

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

181.8

3984

12565

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

181.3

6621

23653

G04BD08

ATC

solifenacin; oral

1.8

181.2

3313

9913

ACC51

NOMESCO Finland

Release of median nerve

1.7

181.0

3962

12490

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

180.6

2035

5145

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.1

180.3

950

1644

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

180.0

7698

28407

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

179.7

6042

21195

XQ800

NOMESCO Finland

Prick test

1.7

179.4

4202

13492

B01AF02

ATC

apixaban; oral

1.5

179.0

6166

21745

D01BA02

ATC

terbinafine; oral

1.3

178.8

14118

57935

C09DA06

ATC

candesartan and diuretics; oral

1.7

178.7

3804

11899

A08

ICPC

Swelling

1.9

178.5

2598

7219

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

178.0

3928

12409

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

177.7

8122

30360

E66.0

ICD-10 Finland

Obesity due to excess calories

4.1

177.5

622

803

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

176.2

13678

55967

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

176.1

3258

9781

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

175.2

2091

5405

C05AA08

ATC

fluocortolone; rectal, topical

1.5

175.2

7270

26657

Z3226

NOMESCO Finland

Physiotherapist

1.4

174.9

9884

38400

L86

ICPC

Back syndrome with radiating pain

1.8

174.9

3226

9676

WX780, ,

SPAT

12.7

174.6

254

105

L14

ICPC

Leg/thigh symptom/complaint

1.6

174.3

4319

14073

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

174.2

7371

27131

S80.0

ICD-10 Finland

Contusion of knee

1.7

174.2

4201

13592

K04.08

ICD-10 Finland

Other specified pulpit

1.6

174.1

4388

14360

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

174.0

6102

21596

N89

ICPC

Migraine

2.1

174.0

2103

5462

N06AB08

ATC

fluvoxamine; oral

2.4

173.9

1394

3036

A05

ICPC

Feeling ill

1.7

173.8

3846

12157

C09CA03

ATC

valsartan; oral

1.6

173.3

4621

15340

SPAT1243

SPAT

Psychiatric/psychological examination

2.2

172.5

1651

3900

F32.8

ICD-10 Finland

Other depressive episodes

2.9

172.0

964

1732

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.6

171.9

5208

17830

X58

ICD-10 Finland

Exposure to other specified factors

1.4

171.6

8208

30932

SPAT1281

SPAT

Other administrative function

1.6

171.4

4385

14403

SPAT1216

SPAT

Assessment of functional ability

1.4

171.3

8015

30079

R13

ICD-10 Finland

Dysphagia

1.7

171.1

3508

10852

EB1VA, ,

NOMESCO Finland

1.5

170.7

6988

25544

K59.0

ICD-10 Finland

Constipation

1.8

170.5

2973

8763

M77.1

ICD-10 Finland

Lateral epicondylitis

1.6

170.1

4310

14122

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

169.6

9726

37862

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

5.1

168.5

463

479

J46

ICD-10 Finland

Status asthmaticus

2.3

168.0

1540

3569

-1, ,

ICD-10 Finland

1.9

167.2

2666

7635

H29

ICPC

Ear symptom/complaint other

1.5

167.2

6190

22156

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

166.9

2787

8102

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

166.8

5697

20037

R01AD11

ATC

triamcinolone; nasal

1.6

166.7

4695

15792

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

166.2

17726

75778

XKD00

NOMESCO Finland

Uroflowmetry

1.4

165.9

7678

28739

R5110, ,

SPAT

1.7

165.5

3265

9987

WX320

NOMESCO Finland

Spinalanesthesy

1.3

165.3

13187

54104

A10BX04

ATC

[U] exenatide

4.2

165.1

555

692

A97

ICPC

No disease

1.4

164.8

10299

40660

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

164.8

3251

9944

J96.1

ICD-10 Finland

Chronic respiratory failure

2.7

164.7

1055

2047

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

164.2

4483

14963

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

163.9

2722

7898

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

163.6

5584

19633

G04CA02

ATC

tamsulosin; oral

1.4

163.1

11401

45826

K85

ICPC

Elevated blood pressure

1.4

162.6

7989

30235

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.3

161.7

1418

3221

F43.01

ICD-10 Finland

Acute stress reaction moderate

2.8

161.6

977

1835

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

161.5

2527

7191

OAB72, ,

SPAT

3.5

161.4

691

1041

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.7

161.0

650

938

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

160.6

3084

9357

R06AX13

ATC

loratadine; oral

1.4

160.1

8632

33214

R07.0

ICD-10 Finland

Pain in throat

1.6

159.9

4122

13558

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

159.9

3696

11816

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

159.6

6429

23404

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.4

159.6

1311

2889

B01AF01

ATC

rivaroxaban; oral

1.5

159.0

6163

22258

WX402

NOMESCO Finland

General anaesthesia

1.3

158.8

11920

48423

H81

ICPC

Excessive ear wax

1.4

158.5

8946

34693

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.9

158.3

934

1730

G04CA01

ATC

alfuzosin; oral

1.5

158.0

5839

20877

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.9

158.0

2544

7308

R50.9

ICD-10 Finland

Fever, unspecified

1.4

157.4

8419

32339

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

157.2

3870

12577

C03AA03

ATC

hydrochlorothiazide; oral

1.6

157.1

4349

14559

A06AC51

ATC

ispaghula, combinations; oral

1.9

156.9

2539

7304

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

156.9

4369

14646

L60.0

ICD-10 Finland

Ingrowing nail

1.8

156.9

2590

7500

D09

ICPC

Nausea

1.8

156.5

2748

8114

OAB48, ,

SPAT

1.4

156.3

8407

32321

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

156.3

3851

12518

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

155.7

8034

30657

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.6

155.4

1053

2106

F40.1

ICD-10 Finland

Social phobias

2.3

155.3

1474

3468

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.2

155.2

768

1277

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

155.1

2746

8128

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

155.1

10391

41451

C01DA14

ATC

isosorbide mononitrate; oral

1.4

154.5

7103

26528

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.7

154.4

979

1889

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

154.0

5891

21210

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

153.8

1845

4777

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

153.6

19341

84291

J01DA09

ATC

[U] cefadroxil

1.3

153.4

15308

64733

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

152.8

2223

6172

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

152.7

1766

4508

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

152.5

17884

77236

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.9

152.3

864

1564

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

151.8

5422

19238

L29

ICPC

Musculoskeletal sympt/complt other

1.6

151.5

4555

15548

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

151.3

5070

17741

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

150.6

6536

24134

M01AH02

ATC

rofecoxib; oral

1.5

150.5

6275

22988

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

150.3

2335

6627

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

149.9

13901

58169

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

149.4

5753

20735

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

149.4

8265

31913

G47.4

ICD-10 Finland

Narcolepsy and cataplexy

134.3

149.1

204

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

148.8

4397

14946

N03AX11

ATC

topiramate; oral

2.3

148.8

1356

3134

R07

ICPC

Sneezing/nasal congestion

1.6

148.6

3865

12735

SPAT1059

SPAT

Spirometry at the office

1.8

148.5

2582

7598

M77.4

ICD-10 Finland

Metatarsalgia

1.7

148.4

3184

9969

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

148.3

16146

69020

R03AK11

ATC

formoterol and fluticasone; inhalant

2.3

148.1

1315

3004

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

147.8

8448

32801

N05AN01

ATC

lithium; oral

2.3

147.5

1288

2920

ZXA10

NOMESCO Finland

Bilateral

1.4

147.4

9869

39330

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.0

147.3

2000

5420

F31

ICD-10 Finland

Bipolar affective disorder

3.2

147.3

735

1229

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.7

147.2

935

1806

M54.3

ICD-10 Finland

Sciatica

1.7

147.1

3073

9548

J01EA01

ATC

trimethoprim; systemic

1.3

147.1

14480

61064

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

146.9

9590

38063

H02AB07

ATC

prednisone; oral

1.4

146.8

7173

27081

E29.1

ICD-10 Finland

Testicular hypofunction

3.3

146.7

686

1099

XF404

NOMESCO Finland

Ambulatory ECG

1.6

146.5

4433

15150

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.0

146.0

777

1353

L90

ICPC

Osteoarthrosis of knee

1.7

145.8

3139

9837

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.0

145.7

799

1417

J05AB01

ATC

aciclovir; systemic

1.3

145.5

12097

49812

F43.2

ICD-10 Finland

Adjustment disorders

2.6

145.3

985

1971

J01

ICD-10 Finland

Acute sinusitis

1.7

145.1

3031

9417

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

145.0

3728

12246

M15

ICD-10 Finland

Polyarthrosis

1.8

144.8

2375

6861

WZC30

NOMESCO Finland

Teaching

1.4

144.7

8198

31773

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

144.4

13096

54586

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

144.1

3040

9471

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.8

144.0

2674

8028

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

143.9

4115

13874

H02.3

ICD-10 Finland

Blepharochalasis

1.7

143.8

3101

9721

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

143.5

3151

9927

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

143.2

10943

44492

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.0

142.9

765

1337

SCA04

NOMESCO Finland

Guidance on care of mouth and oral mucosa

10.5

142.5

228

114

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

142.0

6971

26332

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

141.3

3813

12675

S21

ICPC

Skin texture symptom/complaint

1.4

141.3

7694

29606

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

141.2

23057

103369

R03AC13

ATC

formoterol; inhalant

1.8

141.1

2506

7421

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

141.1

1824

4855

3478X

ICD-9 Finland

Cataplexy and narcolepsy[MUUT ORGANISET UNIHÄIRIÖT]

+∞

140.9

177

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.1

140.9

1645

4214

G47.8

ICD-10 Finland

Other sleep disorders

2.7

140.9

913

1783

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.8

140.5

540

751

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

140.2

1751

4602

H13

ICPC

Plugged feeling ear

1.4

140.1

10082

40602

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

140.1

21456

95473

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

140.1

2319

6717

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

139.7

4806

16903

J01CA08

ATC

pivmecillinam; oral

1.2

139.6

23377

105067

N07BA03

ATC

varenicline; oral

1.8

139.2

2541

7588

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

139.1

5370

19351

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

139.0

4298

14758

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

138.8

4944

17517

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

138.7

6007

22153

K07.60

ICD-10 Finland

Snapping jaw

1.7

138.7

2857

8840

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.4

138.6

1127

2471

U07

ICPC

Urine symptom/complaint other

1.6

138.3

3781

12607

SPAT1238

SPAT

Brief therapy

2.5

138.3

1056

2246

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

138.1

4930

17476

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

138.0

6465

24200

J01FA15

ATC

telithromycin; oral

1.5

137.8

5091

18179

P20

ICPC

Memory disturbance

1.5

137.7

6142

22778

J02AC02

ATC

itraconazole; systemic

1.4

137.2

9376

37446

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

136.4

15016

64159

D73

ICPC

Gastroenteritis presumed infection

1.9

136.2

1963

5431

UDC00

NOMESCO Finland

Ear microscopy

1.6

136.1

3982

13495

M54.8

ICD-10 Finland

Other dorsalgia

1.8

136.1

2394

7068

SPAT1325

SPAT

Vaccination

1.3

136.1

18973

83449

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

135.0

3414

11162

N76.0

ICD-10 Finland

Acute vaginitis

1.6

134.9

3523

11613

H92.0

ICD-10 Finland

Otalgia

1.6

134.8

3381

11030

S76

ICPC

Skin infection other

1.7

134.7

2714

8343

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.2

134.5

655

1078

Z2221

NOMESCO Finland

Medical doctor

1.3

134.1

15564

66924

K04

ICPC

Palpitations/awareness of heart

1.7

133.8

2752

8510

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

133.7

7271

27953

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

133.6

5886

21771

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

133.5

3687

12321

SAA04

NOMESCO Finland

Special examination of mouth

1.7

133.1

2935

9254

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

132.8

3338

10895

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

26.3

132.2

150

N30

ICD-10 Finland

Cystitis

1.5

131.9

4422

15456

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

131.6

4515

15862

Z2446

NOMESCO Finland

Social worker

1.6

131.5

3387

11123

SPAT1043

SPAT

Audiometry

1.5

130.8

4986

17912

N05AF03

ATC

chlorprothixene; systemic

2.2

130.8

1324

3202

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

129.6

4954

17806

N06BA12

ATC

lisdexamfetamine; oral

3.3

128.9

610

985

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

128.9

2704

8406

R4190

NOMESCO Finland

Nutritional therapy

1.9

128.6

1919

5371

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.6

127.9

3550

11874

J37.0

ICD-10 Finland

Chronic laryngitis

2.0

127.8

1621

4284

P15

ICPC

Chronic alcohol abuse

2.1

127.6

1479

3777

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

127.6

3563

11935

S10

ICPC

Boil/carbuncle

1.7

127.6

3010

9662

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

127.6

4154

14422

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

127.6

9115

36618

D02

ICPC

Abdominal pain epigastric

1.6

127.1

3251

10655

L11

ICPC

Wrist symptom/complaint

1.5

127.0

4888

17590

P58

ICPC

Psychological, Therapeutic counselling/listening

2.3

127.0

1134

2597

N06AX18

ATC

reboxetine; oral

3.3

126.9

586

931

WZC00, ,

SPAT

1.5

126.8

5610

20755

SPAT1229

SPAT

Assessment of need for aid

1.6

126.7

3732

12662

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.6

126.6

3202

10466

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

125.7

6407

24332

Z00.8

ICD-10 Finland

Other general examinations

1.5

125.3

4301

15105

L04

ICPC

Chest symptom/complaint

1.6

125.0

3253

10709

M10

ICD-10 Finland

Gout

1.8

124.7

2074

6014

F51.1

ICD-10 Finland

Nonorganic hypersomnia

18.6

124.7

156

C09AA05

ATC

ramipril; oral

1.3

124.3

12270

51597

SFA00

NOMESCO Finland

Small restoration

1.4

124.3

7478

29221

N05AX08

ATC

risperidone; systemic

1.5

123.8

4147

14485

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.1

123.5

1316

3250

F41.00

ICD-10 Finland

Moderate panic disorder

2.6

123.1

885

1826

A10BJ01

ATC

exenatide; parenteral

3.6

123.1

514

761

U01

ICPC

Dysuria/painful urination

1.5

122.1

4154

14558

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

121.6

1721

4730

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

121.3

4213

14831

M76.6

ICD-10 Finland

Achilles tendinitis

1.7

121.1

2490

7696

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

120.8

4356

15458

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.8

120.7

2233

6691

T07

ICPC

Weight gain

2.7

120.7

808

1606

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.3

120.7

1102

2549

WZA00

NOMESCO Finland

Concise certificate

1.6

120.7

3460

11661

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

120.0

1940

5574

B02AA02

ATC

tranexamic acid; systemic

1.4

119.8

7671

30268

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

119.8

11792

49539

A10AE04

ATC

insulin glargine; parenteral

1.5

119.7

4771

17284

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.8

119.5

2287

6923

SPAT1104

SPAT

Monitoring of emergency patient

1.6

119.4

3268

10890

C09AA02

ATC

enalapril; systemic

1.3

119.0

9339

38012

SPAT1053

SPAT

Memory test

1.4

118.8

6515

25049

ZXD05

NOMESCO Finland

Urgent procedure

1.2

118.3

17380

76646

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

5.3

118.3

313

312

R4110

NOMESCO Finland

Physiotherapy

1.3

118.2

14977

64926

A03FA02

ATC

cisapride; oral, rectal

1.6

118.1

3630

12433

J45.8

ICD-10 Finland

Mixed asthma

2.0

117.9

1562

4193

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

117.9

4192

14829

R55

ICD-10 Finland

Syncope and collapse

1.4

117.9

5569

20847

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

117.8

3107

10259

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

117.7

2171

6500

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.4

117.4

522

808

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

117.4

9176

37321

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

117.3

2886

9363

RK250, ,

NOMESCO Finland

5.8

117.0

282

254

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

116.6

16216

71048

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

116.5

1916

5536

N06AA10

ATC

nortriptyline; systemic

2.3

116.3

1053

2426

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

116.0

2438

7580

R06AX26

ATC

fexofenadine; oral

1.6

115.9

3579

12269

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.6

115.8

471

684

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.8

115.5

2075

6162

A08AB01

ATC

orlistat; oral

4.2

115.3

395

501

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

115.3

3452

11750

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.4

115.1

5159

19117

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

115.1

2277

6958

N62

ICD-10 Finland

Hypertrophy of breast

1.8

115.1

2066

6134

F60.5

ICD-10 Finland

Anankastic personality disorder

3.0

115.1

622

1094

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

114.9

4188

14891

N39.3

ICD-10 Finland

Stress incontinence

1.6

114.5

3452

11769

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

114.2

1472

3913

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

3.4

114.0

505

780

C09DA03

ATC

valsartan and diuretics; oral

1.8

113.9

2191

6641

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.8

113.4

1896

5507

M54.1

ICD-10 Finland

Radiculopathy

1.8

113.3

1946

5699

R09

ICPC

Sinus symptom/complaint

1.5

113.2

4444

16042

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

113.1

2696

8673

OAB42, ,

SPAT

1.4

113.0

5595

21116

K05.30

ICD-10 Finland

Periodontitis complex

1.4

113.0

7184

28296

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

112.9

3077

10239

E000001, ,

ATC

1.3

112.7

11225

47183

H93.1

ICD-10 Finland

Tinnitus

1.6

112.5

3447

11795

J01DA06

ATC

[U] cefuroxime

1.4

112.2

7557

30034

SPAT1360

SPAT

Extensive global examination

1.5

112.1

3605

12470

F29

ICPC

Eye symptom/complaint other

1.4

111.8

4999

18512

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.6

111.7

787

1607

R30.0

ICD-10 Finland

Dysuria

1.7

111.5

2158

6553

D12

ICPC

Constipation

1.9

111.2

1731

4912

U04

ICPC

Incontinence urine

1.7

111.2

2429

7633

TFP20

NOMESCO Finland

Cardiodefibrillation

1.6

111.0

3267

11073

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

3.0

111.0

603

1064

K07

ICPC

Swollen ankles/oedema

1.8

110.9

2102

6344

N05AB03

ATC

perphenazine; systemic, rectal

1.9

110.8

1667

4677

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

110.6

7048

27762

E03

ICD-10 Finland

Other hypothyroidism

1.6

110.6

2967

9835

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

110.3

3529

12193

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.9

110.1

1540

4215

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

110.0

9667

39943

S22

ICPC

Nail symptom/complaint

1.6

109.5

3231

10958

A06AD11

ATC

lactulose; oral

1.4

109.3

6975

27480

L05

ICPC

Flank/axilla symptom/complaint

1.6

109.1

3017

10074

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

109.0

2282

7087

G03DB01

ATC

dydrogesterone; oral

1.4

108.8

6317

24505

N02AJ13

ATC

tramadol and paracetamol; systemic

2.2

108.4

1124

2745

SPAT1359

SPAT

Use of symptom diary

2.1

108.3

1278

3286

K58

ICD-10 Finland

Irritable bowel syndrome

2.0

107.7

1403

3743

S97

ICPC

Chronic ulcer skin

1.6

107.7

2800

9208

XA421, ,

SPAT

3.9

107.7

402

547

D07XC01

ATC

betamethasone; topical

1.4

107.6

6069

23426

A28

ICPC

Limited function/disability NOS

1.3

107.4

7935

31968

S22.3

ICD-10 Finland

Fracture of rib

1.5

107.4

3436

11870

IBA03

NOMESCO Finland

Psychotherapy evaluation

3.1

107.4

540

908

A08AA62

ATC

bupropion and naltrexone; systemic

4.9

107.4

308

333

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

107.3

2782

9143

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

107.2

5081

19016

C08CA02

ATC

felodipine; oral

1.5

106.8

4298

15589

T74.1

ICD-10 Finland

Physical abuse

2.2

106.6

1046

2496

N02CC07

ATC

frovatriptan; oral

1.7

106.1

2055

6241

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

105.6

1431

3872

K05.31

ICD-10 Finland

Periodontitis pronounced

1.4

105.2

5147

19372

EB1AA, ,

SPAT

1.5

105.2

3444

11957

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.5

105.0

784

1649

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.3

105.0

492

790

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

104.9

4991

18690

SPAT1139

SPAT

Nutrition survey

1.9

104.6

1622

4596

H60

ICD-10 Finland

Otitis externa

1.6

104.5

2714

8921

M75.8

ICD-10 Finland

Other shoulder lesions

1.8

104.4

1896

5648

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

104.3

2280

7165

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

104.2

5481

20895

R01AD59

ATC

mometasone, combinations; nasal

1.7

103.9

2107

6484

K03.00

ICD-10 Finland

Approximal wear

1.5

103.8

3609

12696

L18

ICPC

Muscle pain

1.7

103.6

2134

6596

SGC10

NOMESCO Finland

Pulp capping

1.4

103.5

4896

18313

K07.4

ICD-10 Finland

Malocclusion, unspecified

2.4

103.5

876

1958

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

103.1

4419

16223

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

102.5

2308

7311

R01AD05

ATC

budesonide; nasal

1.5

102.3

3804

13573

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

102.2

8102

32964

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

102.2

2294

7261

3055, ,

Kela drug reimbursment

5.0

102.2

286

302

N06BA07

ATC

modafinil; oral

5.5

102.1

261

251

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

102.1

7724

31213

C09CA07

ATC

telmisartan; oral

1.5

101.7

3449

12066

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

101.7

3666

12995

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

101.6

3512

12338

G43.3

ICD-10 Finland

Complicated migraine

2.3

101.2

895

2041

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

101.0

3059

10434

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

100.3

3368

11757

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

100.3

5596

21547

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

100.2

1343

3620

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.8

100.2

1871

5620

H57.1

ICD-10 Finland

Ocular pain

1.8

99.8

1917

5806

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

99.8

8426

34579

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.4

99.2

5916

23032

S04

ICPC

Lump/swelling localized

1.4

99.0

5501

21164

R52.0

ICD-10 Finland

Acute pain

1.8

98.7

1685

4925

SPAT1252

SPAT

Overall medication plan or its review

1.5

98.1

3171

10975

M01AB55

ATC

diclofenac, combinations; oral

1.6

97.8

3013

10316

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

97.8

2946

10035

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

97.7

3197

11094

HMAK, ,

NOMESCO Finland

1.4

97.7

6260

24652

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.8

97.6

1619

4689

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

3.6

97.6

406

600

N06AA04

ATC

clomipramine; systemic

2.4

97.1

806

1785

R03AC12

ATC

salmeterol; inhalant

1.7

96.9

2082

6511

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

96.7

2079

6502

J01MA14

ATC

moxifloxacin; systemic

1.4

96.6

4319

15977

R06.4

ICD-10 Finland

Hyperventilation

2.3

96.4

852

1942

SXC05

NOMESCO Finland

Other oral or dental procedure

1.5

96.4

3486

12360

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

96.3

2214

7051

ZY000

NOMESCO Finland

Hospital inpatient

2.6

96.2

695

1438

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

4.2

95.6

325

410

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.4

95.5

4404

16387

I50

ICD-10 Finland

Heart failure

1.9

95.3

1331

3640

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.9

95.0

1494

4253

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.6

94.8

2688

9024

D07AA02

ATC

hydrocortisone; topical

1.3

94.8

7699

31406

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

94.8

4706

17747

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.0

94.6

1249

3349

J01AA07

ATC

tetracycline; systemic

1.3

94.6

8104

33306

N06AX17

ATC

milnacipran; oral

2.9

94.5

529

951

N02CC05

ATC

almotriptan; oral

1.7

94.4

1985

6170

C07AB12

ATC

nebivolol; oral

1.9

94.2

1364

3777

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

94.1

5561

21607

S02.51

ICD-10 Finland

Fracture of tooth, open

1.4

93.9

4795

18173

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

93.8

8300

34260

A29

ICPC

General symptom/complaint other

1.4

93.6

6355

25245

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

93.2

5518

21446

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

93.0

2856

9770

D02AE01

ATC

carbamide; topical

1.5

92.9

3215

11292

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.0

92.8

1138

2969

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

92.7

3079

10719

WX110, ,

SPAT

1.5

92.7

3070

10681

D07AB08

ATC

desonide; topical

1.4

92.6

5656

22093

L09

ICPC

Arm symptom/complaint

1.6

92.5

2400

7885

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.7

92.1

2167

6944

N02CC03

ATC

zolmitriptan; nasal, oral

1.6

92.0

2652

8938

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.7

91.8

2032

6406

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

91.6

1908

5915

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

28.2

91.5

102

B01AC04

ATC

clopidogrel; oral

1.3

91.1

7450

30406

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.5

91.1

3139

11014

R30.1

ICD-10 Finland

Vesical tenesmus

2.1

90.7

1002

2511

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

90.7

6004

23748

S01

ICPC

Pain/tenderness of skin

1.6

90.1

2255

7340

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.6

90.1

617

1242

J01CF05

ATC

flucloxacillin; systemic

1.5

90.0

3054

10681

B01AA03

ATC

warfarin; systemic

1.3

89.9

8733

36478

N02CC04

ATC

rizatriptan; oral

1.5

89.5

2818

9693

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.9

89.5

509

924

M75

ICD-10 Finland

Shoulder lesions

1.6

89.0

2143

6907

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.8

88.9

1455

4196

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

158.3

88.8

120

NG1AA, ,

SPAT

1.5

88.8

3244

11523

M19.8

ICD-10 Finland

Other specified arthrosis

1.7

88.7

1723

5235

A02BA04

ATC

nizatidine; systemic

1.5

88.7

3378

12103

M01AB08

ATC

etodolac; oral

1.5

88.7

3376

12095

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

88.7

2689

9170

K86

ICPC

Hypertension uncomplicated

1.4

88.5

5746

22657

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

88.3

3102

10928

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.7

88.2

1930

6065

S82

ICPC

Naevus/mole

1.3

88.1

7094

28880

T78.4

ICD-10 Finland

Allergy, unspecified

1.6

88.1

2378

7888

R04.2

ICD-10 Finland

Haemoptysis

1.8

88.1

1512

4426

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.1

87.7

1029

2641

R15

ICD-10 Finland

Faecal incontinence

1.9

87.5

1244

3424

ZYC01, ,

SPAT

1.4

87.4

5167

20067

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

87.3

2952

10314

G04BD07

ATC

tolterodine; oral

1.6

87.0

2089

6729

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

86.8

2435

8152

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.3

86.7

757

1717

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.5

86.7

2846

9880

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

86.6

8401

35074

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

86.3

2037

6531

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.8

86.3

1437

4167

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

86.2

1288

3605

J01DC02

ATC

cefuroxime; systemic

1.5

86.1

2746

9470

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.3

85.8

758

1728

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

85.8

3787

13966

B35.3

ICD-10 Finland

Tinea pedis

1.6

85.7

2208

7240

SPAT1255

SPAT

Intravenous administration of medicine

1.5

85.5

3243

11608

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.9

85.3

1349

3847

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

85.3

9025

38091

D01AE16

ATC

amorolfine; topical

1.4

85.2

5608

22151

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

4.5

85.1

262

303

M01AC01

ATC

piroxicam; systemic, rectal

1.3

84.7

6196

24868

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

3.9

84.5

309

414

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.7

84.4

1746

5401

ZXA00

NOMESCO Finland

Right side

1.2

84.2

13412

59295

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

84.2

10498

45182

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

84.1

2683

9253

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

84.1

2566

8761

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

84.1

3362

12162

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

84.0

4165

15692

R03BC03

ATC

nedocromil; inhalant

1.5

83.7

3240

11643

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

83.7

17582

79883

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

83.7

1943

6203

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

83.5

7977

33224

D01AE15

ATC

terbinafine; topical

1.5

83.4

3299

11907

X23

ICPC

Fear sexually transm dis female

1.5

83.4

2739

9507

K03.66

ICD-10 Finland

Tooth plaque

1.4

83.3

3710

13704

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

83.3

3005

10644

AN1

Coronary angiography

1.4

83.1

4846

18772

C10AA03

ATC

pravastatin; oral

1.5

83.0

3105

11080

U05

ICPC

Urination problems other

1.6

82.9

2290

7638

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

82.9

10002

42875

R75

ICPC

Sinusitis acute/chronic

1.6

82.6

2372

7985

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.7

82.6

1859

5886

L84

ICPC

Back syndrome without radiat pain

1.6

82.5

2261

7527

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

82.2

4567

17547

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.6

82.2

2037

6614

A10BH05

ATC

linagliptin; oral

1.6

82.2

2198

7274

N05BA06

ATC

lorazepam; systemic, sublingual

1.6

82.1

2299

7692

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

82.0

4115

15533

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.5

82.0

3266

11804

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.6

82.0

2486

8475

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.4

81.9

4822

18706

N05BA02

ATC

chlordiazepoxide; systemic

2.0

81.9

1025

2696

XKC03

NOMESCO Finland

Water cystometry

1.8

81.8

1344

3880

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

81.8

3527

12948

SPAT1131

SPAT

Colonoscopy

1.8

81.7

1428

4203

R25.2

ICD-10 Finland

Cramp and spasm

1.9

81.7

1169

3224

K03.80

ICD-10 Finland

Irradiated enamel

1.5

81.7

2653

9186

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

81.7

2406

8148

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.1

81.4

910

2292

S02

ICPC

Pruritus

1.7

81.3

1850

5873

H60.8

ICD-10 Finland

Other otitis externa

1.8

81.3

1471

4376

R28

ICPC

Limited function/disability (R)

2.5

81.2

609

1285

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.6

80.9

547

1094

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

80.9

2351

7936

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.3

80.9

748

1741

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.4

80.7

5292

20885

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

3.7

80.7

324

467

N07CA01

ATC

betahistine; oral

1.5

80.6

3305

12014

R04.0

ICD-10 Finland

Epistaxis

1.5

79.8

3425

12559

F51.5

ICD-10 Finland

Nightmares

13.7

79.7

112

130

Kela drug reimbursment

Malignant tumour

0.6

79.5

2129

17065

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

79.4

1217

3435

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.7

79.4

1685

5249

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

79.4

2558

8841

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

79.2

1501

4527

G54.0

ICD-10 Finland

Brachial plexus disorders

1.9

79.1

1234

3504

M70.7

ICD-10 Finland

Other bursitis of hip

1.9

79.0

1137

3143

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.8

78.9

1285

3700

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.8

78.6

1284

3700

P18

ICPC

Medication abuse

3.4

78.5

342

523

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.6

78.5

1959

6372

D01AC03

ATC

econazole; topical

1.5

78.4

2667

9326

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

78.1

2645

9241

P16

ICPC

Acute alcohol abuse

2.2

78.1

783

1887

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

77.9

3057

11013

I20.09

ICD-10 Finland

Unstable angina

1.6

77.9

2380

8127

J30.3

ICD-10 Finland

Other allergic rhinitis

1.7

77.8

1786

5683

U71

ICPC

Cystitis/urinary infection other

1.5

77.7

3219

11722

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.1

77.7

883

2239

J01MA06

ATC

norfloxacin; oral

1.3

77.7

6232

25333

M43.1

ICD-10 Finland

Spondylolisthesis

1.7

77.6

1799

5741

K04.09

ICD-10 Finland

Pulpit UNS

1.6

77.2

2266

7666

D01AC02

ATC

miconazole; topical

1.4

77.2

3534

13116

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

77.2

2213

7446

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

77.0

1308

3817

IHZ04, ,

SPAT

2.5

77.0

597

1281

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.0

77.0

1001

2670

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.7

76.9

1678

5268

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

76.9

1363

4030

G04BD11

ATC

fesoterodine; oral

1.8

76.8

1247

3587

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.5

76.5

3260

11937

M01AB01

ATC

indometacin; systemic, rectal

1.5

76.5

3209

11715

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.6

76.3

1876

6078

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.7

76.3

1535

4711

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

76.2

4503

17470

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

76.2

6555

26898

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.7

76.1

1770

5652

N05CD02

ATC

nitrazepam; oral

2.3

76.1

676

1546

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

76.0

1735

5514

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.7

75.9

1759

5611

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

2.7

75.8

476

915

C10AC01

ATC

colestyramine; oral

1.8

75.8

1254

3629

358

Kela drug reimbursment

liraglutide

4.2

75.7

256

322

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.6

75.6

524

1062

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.2

75.5

750

1800

C01CA24

ATC

epinephrine; parenteral

1.5

75.4

3153

11503

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

2.7

75.2

481

934

R31

ICD-10 Finland

Unspecified haematuria

1.4

74.9

4642

18147

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.1

74.8

823

2060

C08DA01

ATC

verapamil; systemic

1.6

74.8

1786

5743

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.1

74.7

783

1922

M35.7

ICD-10 Finland

Hypermobility syndrome

2.2

74.7

711

1676

ZXA05

NOMESCO Finland

Left side

1.2

74.7

12410

55011

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.3

74.6

660

1506

TAB00

NOMESCO Finland

Lumbar puncture

1.6

74.6

2108

7067

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.8

74.4

1346

4004

R39.1

ICD-10 Finland

Other difficulties with micturition

1.8

74.4

1401

4218

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.2

74.3

709

1673

XG405

NOMESCO Finland

Education on PEF monitoring

2.3

74.3

678

1569

H10

ICD-10 Finland

Conjunctivitis

1.4

74.0

3764

14236

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.7

73.9

1537

4761

M01AH03

ATC

valdecoxib; oral

1.5

73.9

2784

9946

EMB10

NOMESCO Finland

Tonsillectomy

1.5

73.8

3092

11284

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.6

73.7

1787

5768

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

73.7

3907

14883

RD210, ,

NOMESCO Finland

2.1

73.7

820

2062

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

73.7

3314

12257

IEY01

NOMESCO Finland

Psychoeducation, individual

2.9

73.7

421

767

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.6

73.6

1806

5847

L20

ICPC

Joint symptom/complaint NOS

1.6

73.5

1803

5837

K04.00

ICD-10 Finland

Hyperemia of pulp

1.5

73.5

2284

7829

IGY02, ,

SPAT

2.4

73.4

604

1333

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

73.4

3678

13875

H01.0

ICD-10 Finland

Blepharitis

1.4

73.3

3269

12072

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

2.9

73.3

427

787

L10

ICPC

Elbow symptom/complaint

1.5

73.2

2561

9008

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.2

73.1

754

1839

QBJ30

NOMESCO Finland

Correction of abdominal apron

2.9

73.0

405

725

SGB30

NOMESCO Finland

Other complicated root filling

1.3

72.7

6149

25164

F60.8

ICD-10 Finland

Other specific personality disorders

3.1

72.5

361

604

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.6

72.5

2099

7079

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

3.2

72.4

345

561

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.7

72.4

1652

5249

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

3.1

72.3

363

611

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.6

72.3

2078

6996

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

72.2

6215

25495

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.9

72.2

1113

3149

Z02.4

ICD-10 Finland

Examination for driving licence

1.2

71.9

12917

57676

S20.2

ICD-10 Finland

Contusion of thorax

1.5

71.9

2486

8724

NA3AA, ,

SPAT

1.7

71.8

1406

4281

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

71.8

11350

50031

XA800

NOMESCO Finland

Neuropsychological investigation

1.6

71.3

1959

6524

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.5

71.1

2843

10279

SPAT1284

SPAT

Extensive health certificate

1.7

71.1

1396

4255

J05AB11

ATC

valaciclovir; oral

1.3

71.0

7226

30292

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

70.9

2263

7802

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.7

70.8

1662

5320

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.3

70.8

6638

27538

R51.81

ICD-10 Finland

Facial pain NOS

1.9

70.7

1089

3079

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

70.6

3191

11810

A01AB09

ATC

miconazole; local oral

1.4

70.6

4107

15887

G04CB01

ATC

finasteride; oral

1.4

70.6

4614

18185

C09DA07

ATC

telmisartan and diuretics; oral

1.6

70.4

1785

5827

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.7

70.3

1375

4186

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.2

70.2

679

1612

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.5

70.1

2330

8105

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

70.0

5546

22488

L72.1

ICD-10 Finland

Trichilemmal cyst

1.4

69.8

3240

12052

G44.8

ICD-10 Finland

Other specified headache syndromes

2.1

69.7

738

1819

R73

ICD-10 Finland

Elevated blood glucose level

1.8

69.6

1289

3862

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

1.9

69.4

1076

3050

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.7

69.0

1452

4512

A10BG03

ATC

pioglitazone; oral

1.9

69.0

1031

2886

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.9

69.0

1051

2961

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.7

69.0

1603

5117

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

68.9

1854

6144

J01FA01

ATC

erythromycin; systemic

1.3

68.5

7511

31769

R03DA04

ATC

theophylline; systemic, rectal

1.5

68.5

2156

7411

C09BA02

ATC

enalapril and diuretics; systemic

1.4

68.4

3443

12993

EB4VA, ,

NOMESCO Finland

1.3

68.4

5604

22826

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.8

68.4

1137

3296

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

68.2

2659

9564

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

67.8

2993

11028

GD1AD

NOMESCO Finland

Thorax CT examination

1.5

67.7

2506

8919

N02CC06

ATC

eletriptan; oral

1.6

67.5

1703

5554

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.3

67.5

5162

20822

UJD02

NOMESCO Finland

Gastroscopy

1.5

67.4

2088

7150

N05AF01

ATC

flupentixol; systemic

2.2

67.4

663

1586

H02.4

ICD-10 Finland

Ptosis of eyelid

1.8

67.3

1259

3784

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.0

67.2

879

2350

K29.7

ICD-10 Finland

Gastritis, unspecified

1.7

67.1

1582

5070

W19

ICD-10 Finland

Unspecified fall

1.3

66.7

4857

19449

N05AL01

ATC

sulpiride; systemic

2.2

66.6

638

1509

A07AA02

ATC

nystatin; oral

1.5

66.4

2611

9407

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.1

66.3

750

1899

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

66.3

1921

6479

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

66.1

4195

16450

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.8

66.0

1070

3077

NA3BG, ,

SPAT

1.6

66.0

1822

6075

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.4

65.9

2976

11013

R52.1

ICD-10 Finland

Chronic intractable pain

2.7

65.7

435

861

SGB20

NOMESCO Finland

Root filling of tooth with onetwo root canals

1.4

65.7

3107

11594

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

65.7

3350

12670

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.6

65.7

1801

5995

F10.09

ICD-10 Finland

Alcohol intoxication UNS

1.9

65.6

978

2737

P27

ICPC

Fear of mental disorder

2.2

65.5

628

1486

NG2AA

NOMESCO Finland

Patella X-ray examination

1.8

65.4

1212

3632

K08.3

ICD-10 Finland

Retained dental root

1.4

65.4

3504

13366

I50.0

ICD-10 Finland

Congestive heart failure

1.4

65.2

2986

11076

R25.1

ICD-10 Finland

Tremor, unspecified

1.7

65.2

1334

4114

J01AA04

ATC

lymecycline; systemic

1.3

65.2

7056

29787

M62.6

ICD-10 Finland

Muscle strain

1.7

64.9

1494

4758

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.6

64.8

1775

5906

C01BC04

ATC

flecainide; systemic

1.7

64.7

1476

4689

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.6

64.6

1534

4926

N48.1

ICD-10 Finland

Balanoposthitis

1.8

64.4

1122

3300

DAX08

NOMESCO Finland

Fitting of hearing aid

1.5

64.4

2179

7609

R49.01

ICD-10 Finland

Functional dysphonia

1.7

64.4

1307

4022

SFC92

NOMESCO Finland

Other complicated additional procedure necessary for restorative treatment

1.4

64.3

2989

11118

A10BD07

ATC

metformin and sitagliptin; systemic

1.6

64.2

1791

5986

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

64.2

3422

13041

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

64.2

2704

9874

D93

ICPC

Irritable bowel syndrome

2.2

64.0

634

1521

R5140, ,

SPAT

2.6

64.0

439

886

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

63.9

2455

8803

SPAT1234

SPAT

Support of social functional capacity

1.5

63.8

2264

7985

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.7

63.7

1400

4403

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.9

63.6

933

2596

Z08

ICPC

Social welfare problem

2.2

63.6

614

1457

F41.01

ICD-10 Finland

Severe panic disorder

3.1

63.5

325

554

Z12

ICPC

Relationship problem with partner

2.0

63.4

844

2271

G47

ICD-10 Finland

Sleep disorders

5.9

63.3

150

133

R19.4

ICD-10 Finland

Change in bowel habit

1.7

63.2

1258

3850

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.1

63.1

669

1651

K78

ICPC

Atrial fibrillation/flutter

1.4

63.1

3198

12081

IER01

NOMESCO Finland

Psychoeducation, group

3.0

63.0

342

605

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.5

62.9

2188

7685

E000002, ,

ATC

1.3

62.9

5724

23634

M10.0

ICD-10 Finland

Idiopathic gout

1.7

62.7

1397

4410

K05.18

ICD-10 Finland

Chronic gingivitis

1.4

62.6

3402

13006

DM1QA, ,

SPAT

1.6

62.5

1729

5766

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.7

62.3

1431

4554

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

2.6

62.2

439

899

G01AA10

ATC

clindamycin; vaginal

1.3

62.2

6869

29057

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.9

62.2

917

2557

N81.6

ICD-10 Finland

Rectocele

1.4

62.1

2752

10145

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.8

62.1

1088

3206

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

62.1

6248

26130

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030467) Casts [#/volume] in Urine by Automated count

19893

79833

1.42

320.49

3.3

3.1

0.36

0.41

e6/l

2.76

15149

60217

(36304419) Bacteria [Presence] in Urine

19508

78031

1.42

319.95

3.2

3.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

12141

44277

1.53

316.93

3.0

3.6

0.82

mmol/l

5.03

11274

41519

(3000850) Epithelial cells [#/volume] in Urine

15590

59899

1.46

315.94

2.7

2.6

6.00

5.80

e6/l

0.74

13898

53611

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

9408

32399

1.60

314.80

4.8

4.1

31.37

32.82

29.43

7084

22086

(3002030) Lymphocytes/100 leukocytes in Blood

35753

145367

1.56

307.65

5.9

6.2

28.40

28.15

3.80

33584

136862

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

20993

71744

1.75

307.65

3.2

2.9

1152.11

1480.39

ng/l

22.60

17430

61494

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

7304

13333

3.08

307.65

3.3

4.1

5.21

5.09

kpa

24.32

6932

12568

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

35658

138969

1.67

307.65

6.5

6.6

1.22

1.21

mmol/l

2.56

29870

118531

(3041096) Erythrocytes [Presence] in Urine by Automated

20255

80694

1.44

307.65

3.4

3.1

—

(3029937) Albumin [Presence] in Urine by Test strip

19995

78614

1.46

307.65

4.2

3.8

0.00

estimate

0.03

7574

26012

(3031040) Bacteria [#/volume] in Urine by Automated count

46758

198205

1.65

307.65

4.9

4.2

1211.13

1440.48

e6/l

0.39

685

2694

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

13343

49432

1.51

307.65

2.7

3.1

2.44

2.45

mmol/l

10.62

11610

43186

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

49405

204202

1.81

307.65

3.4

2.8

47.70

45.26

u/l

7.18

46323

191842

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

24297

89247

1.64

307.65

2.6

2.5

59.04

62.82

u/l

1.16

22286

82680

(3035941) MCH [Entitic mass]

71945

351938

3.81

307.65

23.1

18.5

30.24

30.22

1.64

71282

346843

(3013115) Eosinophils [#/volume] in Blood

38332

153583

1.64

307.65

5.8

6.2

0.20

0.19

e9/l

18.97

33846

135214

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

64869

296782

2.21

307.65

4.7

3.9

1.40

1.48

mmol/l

307.65

60351

276083

(3022313) Gas panel - Capillary blood

5605

8757

3.55

307.65

3.2

4.5

—

(3018418) pH of Serum or Plasma

21342

82158

1.51

307.65

3.9

4.1

7.40

0.71

4618

14888

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

14196

48859

1.65

307.65

1.3

33.68

34.75

iu/ml

0.12

4179

15918

(1002224) Polysomnography panel

6721

6727

5.67

307.65

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

18166

61138

1.74

307.65

1.6

1.5

20.49

20.19

nmol/l

1.53

15682

52709

(3020682) Albumin/Creatinine [Ratio] in Urine

22448

80407

1.67

307.65

4.0

3.8

9.38

9.59

mg/mmol

0.22

14402

50967

(3017446) Testosterone [Moles/volume] in Serum or Plasma

6718

20085

1.83

307.65

2.5

2.0

11.88

12.36

nmol/l

4.62

5978

18145

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

65074

288498

2.54

307.65

5.1

4.0

5.95

5.84

mmol/l

85.60

59925

264890

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

28235

102527

1.72

307.65

3.9

3.3

64.68

62.70

ng/l

0.05

18061

66352

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

66242

304134

2.39

307.65

5.3

4.3

2.73

2.79

mmol/l

52.84

61730

282465

(3019309) Folate [Moles/volume] in Red Blood Cells

14442

48750

1.69

307.65

1.8

1.7

1185.59

1156.19

nmol/l

2.94

10950

37015

(3015736) pH of Urine

29291

119280

1.48

307.65

3.5

3.2

5.88

5.90

0.59

2447

9348

(3022096) Basophils/100 leukocytes in Blood

33504

135293

1.55

307.65

5.8

6.2

0.68

0.67

1.04

31213

126456

(3022217) INR in Platelet poor plasma by Coagulation assay

32466

129159

1.57

307.65

15.5

13.5

1.23

1.25

inr

1.36

10517

36920

(3018095) Leukocytes [#/volume] in Urine

25371

103411

1.44

307.65

3.9

3.6

79.44

99.35

e6/l

3.13

18021

71712

(40760892) CBC W Ordered Manual Differential panel - Blood

35383

139350

1.64

307.65

6.1

6.5

—

(3006315) Basophils [#/volume] in Blood

37050

148734

1.62

307.65

5.6

6.0

0.04

e9/l

6.42

32282

129198

(40768797) Stomach Pathology biopsy report

11479

36631

1.76

307.65

1.2

—

(40768804) Tissue Pathology biopsy report

28251

120169

1.38

307.65

2.1

2.0

—

(40761511) CBC panel - Blood by Automated count

68900

325143

2.67

307.65

14.8

11.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

10677

37627

1.57

307.65

2.6

22.66

22.93

1.05

9167

32055

(4200892) Spirometry reversibility

6434

18718

1.88

307.65

1.5

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

30881

111365

1.78

307.65

2.1

1.9

98.65

95.32

pmol/l

24.45

16414

58497

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

57963

228944

2.53

307.65

4.5

3.8

14.65

14.73

pmol/l

11.44

53398

208311

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

25008

95958

1.56

307.65

3.1

3.2

32.10

33.64

u/l

2.29

23572

91193

(3005322) IgE [Units/volume] in Serum or Plasma

5935

17809

1.81

307.65

1.3

241.15

258.96

u/ml

0.35

5493

16438

(3036481) Cortisol [Moles/volume] in Serum or Plasma

8633

24150

1.99

307.65

2.1

2.3

359.96

385.02

nmol/l

22.37

7883

22361

(3026361) Erythrocytes [#/volume] in Blood

71951

352023

3.81

307.65

23.2

18.6

4.54

4.51

e12/l

70.68

70553

341340

(3002582) Erythrocytes [#/volume] in Urine

21720

87363

1.43

307.65

3.4

3.1

68.93

93.15

e6/l

1.61

16680

66465

(3001122) Ferritin [Mass/volume] in Serum or Plasma

35667

130619

1.84

307.65

3.1

2.8

111.48

119.99

ug/l

6.82

33129

121664

(3048689) Calprotectin [Mass/mass] in Stool

11106

36501

1.70

307.65

2.2

2.5

114.40

140.48

ug/g

11.36

8636

29027

(3013512) EKG study

21275

76807

1.64

307.65

4.2

3.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

49046

207789

1.71

307.65

4.6

4.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

62741

268380

2.51

307.65

6.4

5.0

39.76

39.08

mmol/mol

54.99

58718

248972

(3019069) Monocytes/100 leukocytes in Blood

34833

140611

1.57

307.65

6.1

6.4

8.38

8.53

13.19

32639

131986

(3019550) Sodium [Moles/volume] in Serum or Plasma

68257

309937

3.05

307.65

17.6

14.4

139.66

139.62

mmol/l

4.38

66903

301429

(3009343) pH of Capillary blood

7232

13139

3.09

307.65

3.3

4.1

7.41

7.42

2.48

819

1929

(3009261) Glucose [Presence] in Urine by Test strip

35957

149173

1.52

307.65

3.8

3.5

0.01

0.00

estimate

1.41

7545

26516

(3037522) Nuclear Ab [Titer] in Serum

11338

39357

1.60

307.65

1.4

1.3

499.33

557.55

titre

2.39

2179

8062

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

16657

56347

1.71

307.65

1.7

1.6

29649070.93

36882134.73

pmol/l

0.78

13832

46923

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

18105

61688

1.72

307.65

1.8

1.7

0.95

1.28

mg/l

39.28

13550

46853

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

4976

7570

3.63

307.65

3.3

4.8

24.90

24.67

mmol/l

5.52

4661

6937

(3000492) Spirometry study

8554

28143

1.67

307.65

1.5

1.4

—

(3024731) MCV [Entitic volume]

71950

351983

3.81

307.65

23.1

18.5

90.75

90.64

9.24

71286

346870

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

11677

36033

1.83

307.65

1.9

1.7

1.44

1.42

2.29

10278

32066

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

31589

117543

1.72

307.65

2.4

2.2

2943.59

76.57

nmol/l

0.50

28593

106472

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

27691

114335

1.43

307.65

4.0

3.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

11462

40354

1.58

307.65

2.5

2.41

2.33

g/l

35.49

10536

37327

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

54218

225127

1.99

307.65

7.2

7.4

75.89

78.00

u/l

21.32

51133

212401

(3000963) Hemoglobin [Mass/volume] in Blood

71961

352167

3.82

307.65

23.3

18.7

136.57

135.46

g/l

78.31

71314

347086

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

6991

12726

3.08

307.65

3.2

4.0

1.61

1.73

mmol/l

1.51

5290

9109

(3019198) Lymphocytes [#/volume] in Blood

38006

153534

1.62

307.65

5.7

6.0

1.99

1.92

e9/l

7.69

33860

136385

(3012516) Albumin [Mass/volume] in Urine

21492

76263

1.68

307.65

3.4

3.3

389.88

430.81

mg/l

0.59

14151

48405

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

65588

276993

3.17

307.65

5.5

4.4

1.93

2.10

mu/l

2.15

61284

254833

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

63757

284958

2.27

307.65

14.1

11.9

84.29

84.03

ml/min/173m2

1.93

53963

231604

(3044889) 12 lead EKG panel

48005

200622

1.73

307.65

4.0

3.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

71900

351254

3.80

307.65

23.2

18.7

40.80

40.39

3.44

68675

328832

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

19654

70473

1.63

307.65

2.4

2.2

2.92

2.90

mg/l

0.33

16825

60251

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

62986

285935

2.06

307.65

4.3

3.6

1.39

1.25

mmol/l

307.65

58177

264354

(3035350) Ketones [Presence] in Urine by Test strip

35699

147523

1.52

307.65

3.8

3.5

0.00

estimate

0.78

8092

28491

(3007164) IgA [Mass/volume] in Serum or Plasma

16198

57768

1.60

307.65

1.5

1.4

2.38

2.35

g/l

1.25

9873

35559

(3010813) Leukocytes [#/volume] in Blood

71960

352065

3.83

307.65

23.2

18.6

6.85

6.70

e9/l

52.26

70586

341357

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

47995

213375

1.51

307.65

3.5

3.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

13492

45739

1.67

307.65

1.3

8.92

12.58

u/ml

6.16

5246

17855

(3013707) Erythrocyte sedimentation rate by Westergren method

53875

218017

2.10

307.65

4.4

3.8

11.53

11.58

mm/h

0.36

50104

202102

(3015377) Calcium [Moles/volume] in Serum or Plasma

25077

92820

1.63

307.65

2.8

3.5

2.35

mmol/l

0.47

22113

81930

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

65281

299170

2.25

307.65

4.8

3.9

4.59

4.70

mmol/l

118.39

61052

279407

(3024561) Albumin [Mass/volume] in Serum or Plasma

31285

121571

1.61

307.65

4.4

4.9

36.10

35.56

g/l

52.11

28955

112992

(3002385) Erythrocyte distribution width [Ratio]

57774

271503

1.54

307.65

17.5

15.4

15.30

14.88

2.09

56904

266485

(3022948) Iron [Moles/volume] in Serum or Plasma

12470

43828

1.59

307.65

2.5

13.59

13.64

umol/l

0.04

11569

40870

(3001604) Monocytes [#/volume] in Blood

36976

148386

1.62

307.65

5.6

6.0

0.58

e9/l

3.72

32231

129032

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

18986

72764

1.50

307.65

1.7

1.6

1.49

1.33

mmol/l

79.08

15736

62079

(3021589) Normoblasts [#/volume] in Blood

31906

132374

1.47

307.65

9.9

9.2

0.00

e9/l

2.68

26292

108602

(3026493) Urate [Moles/volume] in Serum or Plasma

20294

72114

1.66

307.65

2.7

2.5

3310.57

4468.20

umol/l

4.15

17734

63726

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

37599

148630

1.67

307.65

5.2

6.2

10.84

11.52

umol/l

20.91

35444

140859

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

70102

329779

3.27

307.65

11.1

9.5

28.09

25.96

u/l

74.79

67987

318346

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

67653

309944

2.73

307.65

15.6

12.8

20.44

24.13

mg/l

150.37

56136

240152

(3028707) Methadone [Presence] in Urine by Screen method

2477

5167

2.57

307.65

3.2

2.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

69839

327936

3.16

307.65

17.6

14.6

77.16

76.06

umol/l

13.59

69821

327785

(3013650) Neutrophils [#/volume] in Blood by Automated count

41270

172802

1.57

307.65

7.8

9.3

4.18

4.08

e9/l

11.62

36107

151140

(3006504) Eosinophils/100 leukocytes in Blood

34658

139790

1.57

307.65

5.8

6.1

2.89

2.82

6.87

32414

131037

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

22541

82478

1.62

307.65

2.3

2.1

195.34

215.03

u/l

2.07

21138

77467

(3007461) Platelets [#/volume] in Blood

71921

351606

3.80

307.65

23.2

18.6

254.42

252.69

e9/l

9.93

70714

341912

(3009508) Creatinine [Moles/volume] in Urine

24318

84282

1.77

307.65

3.3

3.2

7.98

7.80

mmol/l

0.53

20470

71987

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

32560

125413

1.65

307.65

5.9

6.0

1.21

mmol/l

4.12

29675

114634

(3013826) Glucose [Moles/volume] in Serum or Plasma

42074

169264

1.71

307.65

4.9

4.6

6.64

6.66

mmol/l

0.53

39451

156596

(3021601) Nitrite [Presence] in Urine by Test strip

35668

147511

1.52

307.65

5.0

4.7

0.00

estimate

0.17

7849

27094

(3023103) Potassium [Moles/volume] in Serum or Plasma

68410

310870

3.10

307.65

17.7

14.5

3.96

mmol/l

0.45

66970

301655

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

16098

61364

1.48

307.65

1.7

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

18811

66635

1.65

307.65

1.3

1.27

1.87

u/ml

9.96

5191

17862

(3018010) Neutrophils/100 leukocytes in Blood

35234

143147

1.56

307.65

5.7

6.0

56.96

57.12

1.73

33047

134697

(3026008) Bacteria identified in Urine by Culture

21576

88468

1.40

303.83

3.2

2.9

—

(3022145) Colonoscopy Study observation

9043

31103

1.60

303.18

1.3

1.4

—

(3011288) Drugs identified in Urine by Screen method

3459

8925

2.08

293.63

3.5

2.9

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2273

4936

2.46

286.36

2.0

1.7

189.46

197.52

pmol/l

2.48

2146

4700

(3003458) Phosphate [Moles/volume] in Serum or Plasma

9905

35287

1.55

284.10

5.5

6.1

1.05

1.04

mmol/l

1.17

9199

32913

(3023368) Bacteria identified in Blood by Culture

18758

76009

1.40

277.61

4.3

4.2

—

(1761868) Lipid panel - Serum or Plasma

25566

109034

1.35

275.23

2.9

2.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

3045

7662

2.13

275.01

1.9

1.6

36.60

43.66

nmol/l

43.07

2961

7496

(3019225) pH of Specimen

7684

26084

1.61

269.40

4.2

4.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

11956

44891

1.47

265.82

1.9

1.8

—

(40761536) Microorganisms panel - Urine sediment

7276

24502

1.62

263.04

4.2

3.7

—

(3000494) Fungus identified in Specimen by Culture

9139

32490

1.54

262.74

1.5

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2534

6018

2.25

262.55

3.0

3.1

24.97

24.44

mmol/l

7.58

2485

5858

(3026782) Osmolality of Urine

14564

57010

1.42

259.26

2.9

2.8

538.18

543.59

mosm/kgh2o

1.74

12401

49033

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

10718

39627

1.49

256.07

2.3

2.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

3768

10565

1.92

253.97

2.7

2.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

9405

33934

1.52

251.88

1.8

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5628

17906

1.70

251.84

3.1

3.4

4.50

4.52

pmol/l

0.64

4967

16044

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

11631

43954

1.46

248.26

2.4

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

9252

33509

1.51

242.64

1.7

1.8

—

(3016879) Cocaine [Presence] in Urine

4327

12931

1.80

239.36

2.6

2.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

7787

27402

1.55

232.01

3.5

3.3

—

(3000764) Benzodiazepines [Presence] in Urine

4564

13998

1.76

231.39

2.6

2.0

—

(3028300) Cannabinoids [Presence] in Urine

4593

14153

1.75

229.10

2.6

2.0

—

(3027008) Opiates [Presence] in Urine

4581

14120

1.75

228.25

2.4

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

31957

143370

1.30

226.42

2.5

2.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

13550

53690

1.40

219.77

4.0

3.5

405.29

531.90

ng/l

0.84

9766

40160

(3027944) Amphetamines [Presence] in Urine

4492

13929

1.74

218.91

2.5

1.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

6405

21817

1.59

218.57

3.7

3.8

1.23

mmol/l

1.96

5552

19093

(3013139) Helicobacter pylori Ag [Presence] in Stool

5672

18781

1.63

216.90

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

19913

84204

1.33

212.57

4.9

4.7

2.83

3.34

ug/l

0.82

17827

75804

(1616796) Gas panel - Central venous blood

2244

5603

2.14

205.69

3.6

3.5

—

(3033658) Prothrombin time (PT) actual/Normal

17715

74194

1.33

199.27

3.9

4.0

91.29

90.53

3.36

17195

72377

(3010421) pH of Blood

2515

6703

2.00

194.51

4.0

3.7

7.42

0.08

2335

6059

(36660697) Celiac disease serology panel - Serum

6752

23977

1.53

190.62

1.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

2236

5785

2.06

187.08

4.1

3.8

5.08

4.96

kpa

10.48

2192

5638

(3012501) Base excess in Blood by calculation

2235

5784

2.06

186.86

4.1

3.8

2.46

2.49

mmol/l

0.19

1564

3793

(3027315) Oxygen [Partial pressure] in Blood

2243

5825

2.05

185.81

4.1

3.8

8.75

8.66

kpa

1.43

2199

5677

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2022

5103

2.11

180.21

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

3039

8889

1.83

178.73

1.4

8.71

10.26

u/l

7.11

2494

7276

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4753

15793

1.62

177.75

1.1

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5934

20796

1.54

177.12

1.2

125.47

148.50

iu/ml

4.10

2191

7884

(3021387) Prolactin [Units/volume] in Serum or Plasma

3707

11548

1.72

176.61

1.7

1.6

307.78

313.64

mu/l

0.30

3285

10467

(3025941) Bacteria identified in Stool by Culture

5030

16978

1.59

176.42

1.3

1.2

—

(40758558) Short blood count panel - Blood

17628

74888

1.31

174.87

5.9

7.2

—

(3021901) Oxygen saturation in Capillary blood

1810

4472

2.15

169.97

2.7

2.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

2207

5900

1.99

168.99

3.4

3.6

8.37

8.34

kpa

0.31

2165

5739

(3001019) Free T4 and TSH panel - Serum or Plasma

4714

15843

1.60

167.97

1.7

1.6

—

(3042936) Bacteria identified in Isolate by Culture

10262

40387

1.39

167.66

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

21589

94673

1.28

166.14

2.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

6103

21824

1.51

165.47

3.6

4.1

0.64

0.67

0.32

1834

7042

(3017143) Hepatitis C virus Ab [Presence] in Serum

9873

38700

1.39

164.93

1.7

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

5558

19531

1.53

163.23

2.4

2.3

20.48

23.12

au/ml

1.17

415

1595

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5651

19945

1.53

162.66

3.8

4.0

89.82

90.18

ng/l

0.10

4836

17336

(3023323) Follitropin [Units/volume] in Serum or Plasma

4361

14496

1.61

162.31

1.4

1.3

23.65

27.19

iu/l

9.71

3723

12491

(3025159) Blasts/100 leukocytes in Blood

6037

21633

1.51

161.89

3.8

4.3

0.23

0.33

0.45

1535

5912

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

5136

17794

1.55

160.56

1.3

47.91

53.72

au/ml

0.86

218

900

(3019150) Specific gravity of Urine by Refractometry

15487

65257

1.31

160.53

4.1

3.8

1.02

kg/l

0.77

2194

10137

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8538

32780

1.41

160.33

2.4

2.9

7.10

8.80

umol/l

12.19

7214

28525

(3021440) Promyelocytes/100 leukocytes in Blood

6291

22865

1.48

157.31

3.8

4.3

0.11

0.12

0.18

1773

7071

(3017181) Myelocytes/100 leukocytes in Blood

6564

24083

1.47

156.60

3.8

4.2

0.89

0.95

0.88

2036

8248

(3011397) Hemoglobin [Presence] in Urine by Test strip

16280

69287

1.30

155.98

3.8

3.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

5947

21533

1.49

151.16

2.4

2.8

10.50

10.59

g/l

0.79

5336

19821

(40767503) Oxygen content in Capillary blood by calculation

1995

5458

1.94

142.96

2.6

2.4

16.89

16.25

7.66

1084

2711

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

11976

49354

1.33

142.90

2.9

2.7

1.01

1.20

e6/l

2.25

6636

27889

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5535

20031

1.49

140.53

2.1

1.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

6727

25323

1.43

139.42

2.2

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4738

16629

1.53

138.97

7.0

7.3

25.01

24.65

mmol/l

9.40

4693

16480

(46235355) HIV 1 and 2 tests - Meaningful Use set

15667

67186

1.28

138.73

2.1

1.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3254

10464

1.66

137.19

1.6

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

7924

30794

1.39

137.06

1.8

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

4881

17313

1.51

136.24

2.1

2.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1176

2665

2.34

134.76

1.2

36.82

27.54

nmol/l

0.54

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3420

11193

1.63

134.67

1.3

1.2

0.63

0.94

u/ml

1.09

316

939

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

11213

46121

1.32

134.62

3.0

2.8

3.07

3.00

e6/l

0.22

5885

24852

(3028026) IgM [Mass/volume] in Serum or Plasma

4698

16590

1.52

133.78

1.7

1.9

1.22

1.34

g/l

3.31

4244

15191

(3019060) Gas panel - Arterial blood

4856

17282

1.51

133.32

4.5

4.9

—

(3017732) Neutrophils [#/volume] in Blood

5511

20159

1.47

132.29

2.6

2.8

4.65

4.98

e9/l

1.22

4445

16408

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

7917

30989

1.38

130.71

1.8

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

7832

30643

1.38

129.56

2.4

2.6

1.82

1.73

9.47

6874

27200

(3027801) Oxygen [Partial pressure] in Arterial blood

7898

30988

1.38

128.36

7.1

7.3

11.73

12.84

kpa

62.72

7536

29508

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7901

31007

1.38

128.22

7.1

7.3

5.16

5.05

kpa

20.48

7546

29526

(3003396) Base excess in Arterial blood by calculation

7902

31026

1.38

127.82

7.1

7.3

1.15

0.96

mmol/l

3.90

6385

24454

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

16448

71565

1.26

127.59

2.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

8613

34311

1.36

127.25

7.0

6.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6975

26849

1.40

126.86

2.5

39.32

45.41

u/l

0.63

5921

23055

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2495

7629

1.74

126.02

1.4

291.80

269.56

ug/g

4.16

1367

4470

(3020630) Protein [Mass/volume] in Serum or Plasma

5785

21688

1.43

121.65

2.2

2.6

66.98

66.36

g/l

7.73

5207

19783

(3003327) Ova and parasites identified in Stool by Light microscopy

3071

10069

1.63

119.77

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5474

20447

1.44

117.19

1.6

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6672

25835

1.39

116.60

2.1

2.3

0.22

0.21

g/l

22.46

6213

24025

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4385

15814

1.48

112.23

1.7

1.6

—

(3016502) Oxygen saturation in Arterial blood

7045

27723

1.37

111.31

7.4

7.7

95.28

95.88

10.75

6813

26613

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

15411

67439

1.25

111.05

4.3

4.1

21.95

21.97

0.05

6913

31894

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5903

22627

1.40

109.04

2.5

2.2

6.14

7.66

ug/l

6.07

5052

19692

(3020961) Endomysium IgA Ab [Titer] in Serum

4032

14374

1.50

109.04

1.1

200.14

202.05

titre

0.01

416

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

11348

48052

1.28

106.94

3.1

2.9

0.69

0.79

ug/l

18.15

7340

30948

(3014111) Lactate [Moles/volume] in Serum or Plasma

6258

24325

1.38

106.31

6.9

7.0

1.37

1.35

mmol/l

0.37

6085

23710

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3407

11774

1.54

106.29

2.0

1.9

39.33

39.44

u/l

0.11

3017

10532

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

8402

34185

1.33

106.28

1.5

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3972

14197

1.49

105.99

2.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

6259

24390

1.38

104.64

7.3

7.6

9.78

9.61

mmol/l

1.00

5939

23175

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4034

14527

1.48

103.73

2.4

2.3

6219.35

6146.26

u/l

0.04

1410

6004

(3023520) Reticulocytes [#/volume] in Blood

5821

22477

1.39

102.69

2.5

2.7

72.29

68.48

e9/l

11.31

4419

16872

(3006184) Hemoglobin [Mass/volume] in Capillary blood

2008

6140

1.74

101.19

2.2

133.20

129.10

g/l

9.29

1479

4520

(3018677) aPTT in Platelet poor plasma by Coagulation assay

10345

43721

1.28

98.01

2.0

2.2

29.93

29.76

1.84

10025

42435

(3028271) Lactate [Moles/volume] in Capillary blood

1473

4132

1.89

97.94

2.0

1.8

1.71

1.76

mmol/l

0.92

1443

4022

(3012544) pH of Venous blood

6692

26626

1.35

97.76

4.1

3.9

7.37

7.38

1.21

178

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

732

1553

2.49

96.42

2.3

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5701

22174

1.38

95.96

3.0

2.9

172.21

213.36

ng/l

9.82

5168

20156

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1338

3662

1.93

95.61

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2223

7104

1.66

95.45

1.5

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1633

4778

1.81

95.30

2.9

3.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

882

2057

2.26

94.84

2.0

2.2

19.53

19.24

nmol/l

0.34

833

1952

(4094501) Cardiovascular stress test using bicycle ergometer

2151

6829

1.67

94.65

1.1

—

(3002032) Base excess in Venous blood by calculation

6454

25666

1.35

94.40

4.2

4.0

1.95

1.80

mmol/l

2.55

5528

21688

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2521

8348

1.61

94.13

1.4

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6470

25752

1.35

94.08

4.2

3.9

5.91

5.80

kpa

13.36

6263

24970

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3289

11584

1.51

93.84

2.1

1.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3395

12069

1.50

92.67

1.5

1.6

13.66

14.76

u/ml

0.15

366

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1315

3619

1.92

92.49

1.2

1.3

1.04

1.27

nmol/l

0.17

1269

3483

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1310

3610

1.92

91.78

1.2

1.3

0.31

0.22

nmol/l

0.53

237

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3834

14054

1.45

89.77

8.8

9.7

24.53

24.19

mmol/l

8.61

3680

13581

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3021

10546

1.52

89.74

1.9

1.8

—

(3003129) Base excess in Capillary blood by calculation

326

437

3.93

89.08

1.5

2.0

0.61

0.41

mmol/l

0.32

315

397

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

1170

3154

1.96

87.29

2.1

2.0

24.79

27.38

mg/l

0.76

352

795

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2741

9438

1.54

86.59

1.6

270.98

292.60

titre

0.14

112

391

(3036180) Methadone [Presence] in Urine

668

1429

2.47

86.57

3.2

2.0

—

(3011985) Renin [Units/volume] in Plasma

1259

3494

1.91

86.42

1.4

1.6

64.68

60.92

mu/l

0.25

1121

3141

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2325

7712

1.60

86.13

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1196

3265

1.94

86.10

1.2

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1706

5232

1.73

85.02

1.2

111.54

147.48

titre

0.39

115

(3014765) Yersinia sp identified in Stool by Organism specific culture

2500

8473

1.57

84.60

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2505

8501

1.57

84.30

1.2

—

(3000991) Gas panel - Venous blood

5879

23441

1.34

83.97

8.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

1213

3361

1.91

83.65

1.9

1.7

89.86

89.93

0.14

1200

3302

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2587

8862

1.55

83.56

1.8

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

687

1516

2.39

83.48

11.6

12.1

0.60

0.63

mmol/l

1.58

639

1388

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

3114

11107

1.49

83.47

1.7

1.6

4.19

3.60

mg/l

1.67

2490

7556

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3338

12088

1.47

83.01

1.1

9.21

7.36

u/ml

0.09

196

(3008898) HLA-B27 [Presence]

2974

10520

1.50

82.95

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2473

8401

1.56

82.84

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2602

8971

1.54

81.66

1.6

1.7

1.21

1.16

g/l

17.97

2469

8529

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1171

3238

1.91

81.25

1.3

1.4

336.57

388.68

pmol/l

0.56

1027

2812

(4146454) Self-monitoring of blood glucose

965

2490

2.05

81.10

2.7

2.8

—

(40761535) Cells panel - Urine sediment

5771

23069

1.34

80.89

3.6

3.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2524

8710

1.54

78.86

1.7

1.8

0.24

0.23

g/l

6.96

2391

8249

(3045414) Leukocytes [Presence] in Urine

3473

12817

1.44

78.23

1.8

—

(3023419) Bacteria identified in Sputum by Culture

1259

3629

1.83

77.04

2.5

—

(3002256) Pathology report gross observation

8948

38219

1.26

75.79

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

5269

21111

1.33

72.34

3.5

3.3

4.67

4.60

kpa

1.42

5073

20395

(40768443) Skin Pathology biopsy report

3334

12395

1.43

72.06

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2294

7909

1.54

71.90

1.3

30.73

37.66

u/ml

0.59

121

508

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4307

16743

1.37

71.90

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3542

13353

1.41

70.85

4.5

4.4

24.25

24.04

mmol/l

3.55

3455

13042

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7685

32488

1.27

70.55

3.5

4.4

233.37

245.24

u/l

10.88

7221

30809

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6269

25908

1.29

68.73

8.0

124.37

120.74

g/l

32.98

6128

25162

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1839

6116

1.59

67.30

1.3

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1871

6265

1.58

66.55

2.2

2.3

150.85

98.58

ug/min

3.09

1119

3756

(3042517) Benzodiazepines panel - Urine

221

275

4.23

66.23

3.3

3.1

—

(3020891) Body temperature

2866

10520

1.45

66.23

4.7

4.8

—

(3045424) Erythrocytes [Presence] in Urine

1479

4673

1.67

66.18

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

512

1098

2.46

66.16

2.1

2.0

153.32

120.45

umol/l

1.16

263

567

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2075

7146

1.54

65.33

1.3

1.4

483.13

537.72

mg/l

3.06

1971

6821

(3016244) Insulin [Units/volume] in Serum or Plasma

698

1732

2.13

64.92

3.4

3.0

31.41

24.19

mu/l

4.13

651

1620

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2147

7489

1.52

63.77

2.1

2.0

10.56

11.02

mg/l

1.55

1972

7003

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2107

7323

1.52

63.63

1.3

6.60

9.80

u/ml

1.51

327

1156

(3004716) Salmonella sp identified in Stool by Organism specific culture

4200

16591

1.35

63.07

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1293

4007

1.71

62.11

5.4

5.0

362.40

368.77

umol/l

0.75

1126

3475

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1864

6340

1.56

61.99

1.1

1.62

2.47

u/ml

3.83

946

3226

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1437

4591

1.66

61.68

1.4

1.3

21.70

25.94

u/l

5.26

1148

3828

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

410

814

2.65

61.66

2.1

2.5

1.12

1.16

ug/l

0.15

381

778

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2070

7226

1.52

61.25

1.3

5.92

7.03

u/ml

0.25

223

760

(3034770) Mitochondria Ab [Titer] in Serum

2208

7821

1.50

60.98

1.2

1.3

951.80

955.94

titre

0.01

219

(3049717) Cytology report of Urine Cyto stain

2670

9823

1.44

60.89

2.5

2.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

11768

52809

1.20

60.78

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

5519

22792

1.29

60.45

2.6

68.22

66.92

ml/min/173m2

1.27

2350

8686

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

12384

55944

1.19

59.28

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5997

25104

1.28

58.99

1.4

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1829

6279

1.54

58.38

1.2

1.3

3.74

3.72

mmol/l

0.50

1715

5898

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2583

9521

1.44

58.29

1.9

1.7

—

(3021788) Differential panel - Synovial fluid

1482

4844

1.62

58.20

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2585

9546

1.44

57.76

2.2

2.4

423.65

577.10

ug/l

1.87

2398

8919

(3024980) IgG subclass 4 [Mass/volume] in Serum

1413

4576

1.63

57.56

1.5

1.6

0.75

0.76

g/l

0.13

1034

3484

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2377

8651

1.46

57.34

1.1

4.72

5.50

u/ml

0.30

289

1153

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1265

3986

1.68

57.21

1.2

1.3

29.56

38.19

u/l

1.49

1096

3483

(3004616) Nuclear Ab [Presence] in Serum

1092

3306

1.74

56.96

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2528

9326

1.44

56.79

1.9

2.3

2.87

2.96

g/l

3.98

2243

8343

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2020

7143

1.50

56.23

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1680

5713

1.56

55.92

1.1

5.36

6.10

u/ml

0.92

842

3039

(3003338) MCHC [Mass/volume]

54419

274391

1.15

55.60

19.4

16.2

332.74

332.75

g/l

0.04

54105

272105

(3007566) Smooth muscle Ab [Titer] in Serum

2209

7989

1.46

55.02

1.2

1.3

111.92

123.32

titre

0.25

214

723

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2657

9954

1.42

54.84

1.9

2.3

7.36

7.38

g/l

0.24

2372

8965

(3028192) IgG subclass 2 [Mass/volume] in Serum

964

2846

1.79

54.73

1.3

1.4

2.93

2.98

g/l

0.35

646

1997

(3044290) Cell count panel - Cerebral spinal fluid

1721

5915

1.54

54.66

1.3

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

721

1935

1.96

54.63

1.2

1.3

1.75

2.08

u/ml

0.33

395

1131

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2653

9943

1.41

54.63

1.9

2.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

4250

17167

1.32

54.60

9.0

9.3

93.45

94.09

7.98

4232

17110

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2648

9926

1.41

54.47

1.9

2.3

3.76

3.70

g/l

0.98

2369

8944

(3024139) IgG subclass 3 [Mass/volume] in Serum

962

2847

1.78

54.19

1.3

1.4

0.37

0.41

g/l

3.34

648

1999

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1120

3468

1.71

54.01

1.3

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1810

6308

1.52

53.96

1.4

1.5

940.53

2414.79

e6/l

1.34

1475

5121

(3027135) IgG subclass 1 [Mass/volume] in Serum

962

2852

1.78

53.88

1.3

1.4

6.67

6.83

g/l

0.61

641

2000

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1808

6303

1.52

53.82

1.4

30.45

30.34

e6/l

0.00

1379

4895

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1118

3466

1.70

53.68

1.3

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2153

7785

1.46

53.68

1.4

1.5

10.08

15.35

iu/ml

1.49

185

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1126

3504

1.70

53.33

1.3

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1150

3600

1.69

53.30

1.3

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1127

3512

1.69

53.11

1.3

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1593

5421

1.55

52.87

1.1

0.92

1.26

u/ml

1.15

634

2392

(4062490) Immunoglobulin typing, IgG

959

2859

1.77

52.74

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3756

14978

1.33

52.72

2.8

2.7

0.26

0.29

e6/l

0.57

3652

14555

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1300

4217

1.63

52.64

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2410

8938

1.43

52.58

2.6

2.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1113

3468

1.69

52.48

1.3

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2821

10762

1.39

52.43

1.2

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1694

5860

1.53

52.25

1.2

11.91

14.38

u/ml

0.13

(3026389) Candida sp identified in Specimen by Organism specific culture

1294

4202

1.63

52.18

1.4

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

577

1452

2.09

51.93

1.1

4.62

5.68

nmol/l

0.24

125

266

(3037121) Protein [Mass/volume] in Urine

2572

9676

1.41

51.82

2.9

3.3

0.31

0.33

g/l

0.21

1052

4475

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

517

1247

2.18

51.66

1.1

10.19

10.38

u/ml

0.03

218

(3047007) Chlamydophila sp Ab [Presence] in Serum

1299

4237

1.62

51.47

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1566

5342

1.55

51.43

1.1

1.82

2.14

u/ml

0.60

771

2717

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2219

8149

1.44

51.03

1.7

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4210

17139

1.31

51.02

9.0

9.3

0.66

0.68

1.89

4189

17032

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4214

17161

1.31

50.95

8.9

9.2

1.43

1.35

4.49

4192

17043

(3020191) Ethanol [Moles/volume] in Serum or Plasma

814

2333

1.84

50.85

1.5

1.4

1.41

1.37

promille

0.25

594

1851

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2163

7921

1.45

50.49

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1368

4541

1.59

50.48

1.1

4.20

4.45

u/ml

0.16

648

2244

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1292

4231

1.61

50.39

1.1

4.62

5.41

u/ml

0.71

547

1829

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1390

4638

1.58

50.20

1.1

11.82

12.15

au/ml

0.04

303

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2277

8434

1.43

50.01

2.1

2.4

0.85

0.88

g/l

0.16

1940

7247

(3035637) Corticotropin [Mass/volume] in Plasma

1078

3390

1.68

49.17

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3218

12692

1.35

48.55

3.2

2.9

1.38

1.25

6.93

3202

12624

(44813793) Dust mix specific IgE antibody measurement

716

2009

1.88

47.77

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1432

4870

1.55

47.68

2.0

1.9

5.17

5.14

mmol/24h

0.09

1262

4331

(3040151) Glucose [Moles/volume] in Capillary blood

994

3084

1.70

47.64

13.2

6.2

7.46

7.23

mmol/l

0.66

830

2494

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2454

9303

1.40

47.29

1.9

2.3

10.12

10.25

g/l

0.74

2153

8266

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

950

2918

1.72

47.20

1.1

1.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2117

7822

1.43

47.11

2.6

3.4

2.83

4.07

ratio

0.54

164

630

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

755

2170

1.83

46.80

1.4

1.3

171.92

184.63

pmol/l

0.49

755

2170

(3002079) Sodium [Moles/time] in 24 hour Urine

479

1167

2.16

46.78

1.2

160.45

155.08

mmol/24h

0.61

479

1167

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

478

1165

2.16

46.64

1.6

14.00

5.98

nmol/l

0.32

394

978

(3042631) Mycobacterium sp identified in Specimen

1070

3409

1.66

46.50

2.8

2.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2168

8065

1.42

46.49

2.7

3.4

41.52

44.11

mg/l

0.25

1650

6655

(3034860) Kappa light chains.free [Mass/volume] in Serum

2171

8079

1.42

46.47

2.7

3.4

49.73

71.65

mg/l

1.42

1649

6662

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4168

17155

1.29

46.41

7.0

6.9

24.81

24.47

mmol/l

7.38

4005

16258

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3142

12440

1.34

46.18

3.2

2.9

0.63

0.66

5.93

3130

12391

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1681

5962

1.49

46.13

1.2

43.39

44.00

u/ml

0.04

151

606

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1418

4862

1.54

45.55

1.5

1.4

0.35

0.44

nmol/l

2.59

1113

3856

(3000475) Leukocytes [#/volume] in Synovial fluid

1805

6513

1.47

45.48

1.6

12647.16

13828.28

e6/l

0.42

1308

4744

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2077

7712

1.43

45.00

1.9

2.2

38.15

37.66

g/l

2.93

1788

6709

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1672

5966

1.48

44.56

1.2

3.85

5.68

u/ml

0.49

127

455

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2017

7480

1.43

44.00

2.0

2.3

0.02

0.03

g/l

0.83

1818

6849

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

229

396

3.04

43.94

1.5

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3159

12617

1.33

43.72

1.7

1.8

1.53

1.51

g/l

0.70

2701

10779

(3012565) Volume of 24 hour Urine

494

1260

2.06

43.06

2.0

2.2

1996.71

1964.48

0.25

436

1132

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1328

4548

1.54

42.91

1.6

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1975

7332

1.42

42.83

1.8

1.9

8.47

21.26

iu/l

0.74

716

2709

(3023183) Ammonium ion [Moles/volume] in Plasma

1598

5698

1.48

42.74

2.6

2.8

33.11

34.02

umol/l

0.78

1461

5122

(3018405) Lactate [Moles/volume] in Arterial blood

2427

9344

1.38

42.63

4.0

4.2

1.37

1.39

mmol/l

0.54

2392

9166

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

672

1920

1.84

42.49

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

4009

16635

1.28

41.80

3.6

3.3

132.06

128.40

g/l

19.61

3908

16238

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

666

1910

1.84

41.63

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1104

3658

1.59

41.12

1.0

0.46

0.37

u/ml

0.19

298

965

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1263

4335

1.54

40.43

1.3

1.4

—

(3022621) pH of Urine by Test strip

4566

19337

1.25

40.15

2.9

2.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1523

5452

1.48

39.97

1.9

2.2

0.96

0.79

nmol/l

13.19

1257

4596

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1654

6018

1.45

39.96

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1654

6021

1.45

39.85

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1774

6553

1.43

39.55

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1856

6922

1.42

39.25

2.0

2.3

0.00

g/l

0.22

1665

6312

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1020

3374

1.59

38.30

1.5

1.6

56.18

57.42

0.39

621

2207

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2026

7712

1.39

38.11

3.1

3.9

1.56

1.48

mg/l

3.36

1856

7143

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1822

6832

1.41

37.39

2.0

2.3

0.00

g/l

-0.00

1660

6294

(3027273) Bicarbonate [Moles/volume] in Venous blood

3218

13190

1.29

36.84

3.6

3.4

25.34

25.19

mmol/l

1.56

3110

12779

(3052851) Hemolysis interference index of Serum or Plasma

2232

8681

1.36

36.79

3.0

3.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

1632

6072

1.42

35.01

2.7

3.5

—

(3024928) Oxygen saturation in Venous blood

1549

5714

1.43

34.83

3.7

3.3

—

(3038026) Centromere Ab [Units/volume] in Serum

702

2161

1.71

34.76

1.2

27.46

59.06

u/ml

2.15

101

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1108

3828

1.53

34.50

1.1

1.48

1.51

g/l

1.50

1000

3466

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1362

4919

1.46

34.23

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

425

1119

2.00

34.20

4.0

3.7

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

376

946

2.09

34.09

1.4

14.38

15.15

pmol/l

1.60

318

793

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

683

2106

1.71

33.64

1.2

67.37

71.56

u/ml

0.12

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2705

10975

1.30

33.40

1.3

228.05

226.47

miu/ml

0.07

1215

5179

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

683

2112

1.70

33.31

1.2

43.08

45.24

u/ml

0.09

158

(3016650) Hepatitis A virus Ab [Presence] in Serum

1372

5006

1.45

32.73

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1679

6356

1.39

32.65

1.6

1.7

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

655

2017

1.71

32.44

1.2

5.14

12.19

u/ml

1.39

140

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

545

1594

1.80

32.16

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2012

7865

1.35

32.13

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2637

10720

1.30

32.09

2.0

1.94

2.35

ug/l

0.90

2309

9460

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

921

3103

1.56

32.09

1.1

17.13

28.86

au/ml

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1288

4661

1.46

32.07

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

489

1387

1.86

31.79

1.6

1.36

1.18

nmol/l

2.52

355

1127

(3020876) Protein [Mass/time] in 24 hour Urine

866

2886

1.58

31.62

2.5

1.41

1.25

g/24h

0.70

428

1462

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1135

4022

1.49

31.40

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

940

3204

1.55

31.15

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

730

2343

1.64

31.03

1.3

1.59

1.34

nmol/l

6.27

672

2106

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

648

2021

1.69

30.69

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

2052

8103

1.34

30.66

4.2

4.4

3.86

3.88

mmol/l

0.93

2041

8027

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

479

1367

1.84

30.58

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

481

1376

1.84

30.48

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2929

12175

1.27

29.99

4.1

3.9

50.23

47.76

5.82

2890

12044

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

896

3049

1.55

29.94

1.1

54.36

62.90

au/ml

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

822

2743

1.58

29.88

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

360

939

2.02

29.80

1.1

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

991

3456

1.51

29.63

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1290

4749

1.43

29.39

1.5

1.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

973

3390

1.51

29.23

1.1

1.15

2.09

iu/ml

2.18

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1268

4681

1.43

28.47

3.3

3.1

0.78

0.81

nmol/l

1.23

965

3629

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1238

4559

1.43

28.18

1.1

65.20

3129.87

iu/ml

0.79

292

1028

(3019977) pH of Arterial blood

472

1377

1.80

28.16

2.7

2.5

7.42

0.43

177

437

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

513

1535

1.76

28.16

1.5

5.93

5.98

u/l

0.03

437

1278

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2348

9593

1.29

27.53

1.7

1.6

11.12

5.52

iu/ml

0.35

446

2072

(3044941) Cell count panel - Synovial fluid

1150

4201

1.44

27.34

1.4

—

(3044927) Protein electrophoresis panel - Urine

732

2432

1.59

27.16

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1824

7208

1.34

27.15

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1341

5050

1.40

26.96

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1670

6524

1.35

26.83

1.2

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

517

1577

1.73

26.60

1.5

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

758

2559

1.56

26.30

1.5

31.77

31.37

0.09

430

1672

(3007463) Buprenorphine [Presence] in Urine

4.39

26.05

10.3

6.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

727

2440

1.57

25.87

1.2

1.1

37.61

44.26

mg/l

2.74

586

2072

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

689

2285

1.59

25.79

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

672

2217

1.60

25.71

1.2

1.3

1.95

2.11

mmol/l

2.86

618

2051

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1023

3703

1.46

25.55

1.5

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2551

10646

1.27

25.28

1.3

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1344

5121

1.38

25.25

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3531

15283

1.22

25.20

9.8

9.6

—

(3000012) Reticulocyte production index

1011

3665

1.45

25.07

2.1

2.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

571

1824

1.65

24.85

1.1

8.05

8.49

iu/ml

0.12

128

495

(3025018) Bordetella pertussis Ab [Titer] in Serum

527

1648

1.68

24.84

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

543

1712

1.67

24.83

1.3

5.31

5.30

umol/l

0.01

483

1602

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

732

2485

1.55

24.82

3.6

3.9

—

(3003181) Sodium [Moles/volume] in Urine

1211

4553

1.40

24.62

1.4

63.09

62.95

mmol/l

0.04

961

3613

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

700

2358

1.56

24.56

1.1

244.80

267.01

mg/l

1.64

605

2084

(3016018) Differential panel - Cerebral spinal fluid

879

3112

1.49

24.56

1.4

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1567

6149

1.34

24.48

1.2

1.3

263.92

259.46

u/ml

0.23

980

3991

(3047181) Lactate [Moles/volume] in Blood

2209

9113

1.28

24.05

5.7

5.6

1.31

1.29

mmol/l

0.18

1972

8039

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1109

4124

1.42

24.00

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1191

4489

1.40

23.88

1.1

3.00

2.83

u/ml

0.16

570

2187

(3010144) Erythrocytes [#/volume] in Synovial fluid

733

2522

1.53

23.45

1.4

129427.47

100765.78

e6/l

0.50

503

1729

(3014271) Vancomycin [Susceptibility]

428

1285

1.75

23.34

3.0

2.9

—

(3020491) Glucose [Moles/volume] in Blood

644

2160

1.57

23.06

1.6

1.8

6.66

6.62

mmol/l

0.12

459

1633

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1160

4380

1.40

23.04

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2518

10610

1.25

23.01

1.5

1.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

162

335

2.54

22.94

1.1

1.0

78.58

81.43

ug/l

0.35

140

265

(3019230) Fractional oxyhemoglobin in Venous blood

1223

4667

1.38

22.82

3.7

3.1

65.08

64.34

0.55

1215

4648

(3037756) Immunofixation for Serum or Plasma

1389

5416

1.35

22.66

1.5

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1320

5111

1.36

22.52

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

557

1815

1.61

22.49

1.6

1.5

24.83

24.23

u/ml

0.09

104

374

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1004

3715

1.42

22.38

1.6

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1319

5113

1.36

22.34

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

371

1085

1.80

22.11

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

475

1492

1.67

22.10

1.3

1.2

331.75

321.07

u/l

0.05

433

1402

(3008295) Osmolality of Serum or Plasma

744

2602

1.51

22.10

1.6

1.4

281.12

278.89

mosm/kgh2o

1.58

556

2045

(3020717) Zinc [Moles/volume] in Serum or Plasma

444

1372

1.70

21.94

1.5

23.86

25.29

umol/l

0.42

424

1312

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

830

2974

1.47

21.92

1.2

61.23

64.49

u/l

0.60

740

2683

(3004451) EKG impression Narrative

392

1170

1.76

21.85

1.3

1.2

—

(3017569) Oxygen content in Arterial blood

371

1090

1.79

21.79

2.4

2.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

844

3042

1.46

21.64

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2483

10530

1.25

21.46

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

389

1166

1.75

21.39

1.6

1.9

1.96

1.95

umol/l

0.14

360

1098

(3034891) Synovial lining cells/100 cells in Synovial fluid

420

1289

1.71

21.28

1.5

3.74

4.26

0.27

309

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

491

1575

1.64

21.13

1.3

447.80

445.04

titre

0.00

113

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1192

4594

1.37

20.97

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1129

4317

1.38

20.86

1.3

1.4

7.25

6.97

mmol/l

2.44

1020

3827

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

299

842

1.87

20.12

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1145

4415

1.37

20.11

1.1

120.37

117.10

2.57

1038

3997

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

627

2159

1.53

20.08

1.1

291.81

426.17

mg/l

0.49

561

1941

(3019420) Tryptase [Mass/volume] in Serum or Plasma

483

1564

1.62

20.07

1.4

1.5

6.90

8.42

ug/l

1.60

434

1422

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

297

838

1.86

19.87

1.2

1.3

19.08

20.23

0.09

159

(3014051) Protein [Presence] in Urine by Test strip

1837

7591

1.28

19.80

2.5

2.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

221

562

2.07

19.78

1.9

2.1

14.87

17.06

umol/l

2.06

221

562

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

374

1135

1.73

19.76

2.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2177

9189

1.25

19.64

3.2

0.36

0.34

u/ml

1.56

1261

5164

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

472

1531

1.62

19.50

1.3

61.35

70.38

titre

0.25

131

(3019832) Treponema pallidum Ab [Presence] in Serum

8250

38951

1.13

19.40

1.8

1.7

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

373

1142

1.72

19.13

1.5

1.4

72.68

72.75

0.03

354

1088

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

561

1906

1.55

19.11

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

105

190

2.90

19.03

1.6

1.8

48.05

46.57

umol/l

0.15

105

190

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

194

476

2.14

19.02

2.2

2.4

7.38

7.48

mmol/l

0.10

124

284

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

754

2732

1.45

18.89

1.4

1.5

—

(3023410) Appearance of Cerebral spinal fluid

797

2919

1.44

18.87

1.5

1.6

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

365

1119

1.71

18.65

1.5

1.4

636.56

691.90

mu/l

0.11

346

1065

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

439

1417

1.63

18.52

1.1

1.2

8.35

15.19

u/ml

0.60

142

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

437

1409

1.63

18.52

1.2

1.3

68.74

63.63

0.43

179

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

388

1213

1.68

18.48

1.8

2.3

101.81

224.24

ug/l

0.50

365

1156

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

655

2327

1.48

18.16

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

655

2327

1.48

18.16

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

655

2327

1.48

18.16

1.5

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1185

4680

1.33

17.87

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

617

2178

1.49

17.66

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

684

2466

1.46

17.63

3.2

2.9

58.26

56.72

mg/l

0.04

494

1765

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1180

4668

1.33

17.61

1.3

1.2

4.10

3.80

u/ml

0.33

521

2128

(3004809) Band form neutrophils/100 leukocytes in Blood

1160

4585

1.33

17.42

3.1

3.3

1.39

1.56

0.89

1032

4067

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

468

1561

1.58

17.32

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

231

630

1.93

17.18

1.1

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

204

532

2.01

17.17

1.7

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

571

1998

1.50

17.07

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1212

4836

1.32

17.06

1.3

1.2

3.86

3.71

u/ml

0.10

420

1683

(3006270) Folate [Moles/volume] in Blood

643

2306

1.47

17.05

1.2

369.55

366.43

nmol/l

0.13

555

1937

(3036489) Thrombin time

2622

11460

1.21

16.99

1.9

2.2

21.17

21.52

1.94

2223

9980

(3017354) Segmented neutrophils/100 leukocytes in Blood

746

2754

1.43

16.99

2.9

3.3

56.57

56.74

0.07

632

2311

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

686

2495

1.45

16.92

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1808

11726

0.80

16.79

1.4

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

457

1529

1.57

16.72

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1109

4382

1.33

16.71

2.6

2.5

13.16

13.13

0.48

1097

4329

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

428

1411

1.59

16.65

1.6

1.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

240

672

1.88

16.54

1.3

1.2

121.42

137.51

nmol/l

0.53

186

492

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3411

20831

0.85

16.51

1.4

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

422

1391

1.60

16.44

1.1

21.54

25.18

u/l

0.73

382

1254

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

784

2941

1.40

16.34

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

427

1414

1.59

16.33

1.6

1.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1424

5845

1.28

16.27

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

421

1391

1.59

16.25

1.1

82.06

85.98

u/l

0.45

381

1254

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

784

2952

1.40

16.01

1.6

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1689

10976

0.80

16.00

1.3

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

533

1867

1.50

15.90

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1685

10944

0.80

15.88

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

802

3036

1.39

15.88

3.4

3.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1696

11001

0.80

15.79

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

564

2004

1.48

15.71

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1696

10993

0.81

15.69

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1568

6546

1.26

15.64

1.4

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

236

673

1.84

15.43

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1342

8909

0.79

15.37

1.4

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

336

1065

1.66

15.32

1.1

1.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1146

4617

1.31

15.12

1.6

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

525

1854

1.49

15.09

1.5

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1146

4619

1.31

15.07

1.6

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

398

1325

1.58

14.94

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1345

8889

0.79

14.84

1.4

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

945

3718

1.34

14.73

1.2

52.71

50.77

u/ml

0.07

247

(43055514) Macroprolactin [Presence] in Serum or Plasma

279

850

1.72

14.71

1.5

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1382

9092

0.79

14.66

1.4

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

198

543

1.92

14.59

1.1

1.02

3.20

umol/24h

0.41

281

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

387

1289

1.58

14.51

1.3

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2233

13977

0.83

14.49

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

324

1033

1.65

14.48

1.2

0.30

0.31

g/l

0.09

254

827

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

387

1290

1.58

14.47

1.3

1.5

—

(3020650) Glucose [Presence] in Urine

248

734

1.78

14.44

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1547

6511

1.25

14.43

1.4

21.51

19.65

u/ml

0.13

127

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

302

949

1.67

14.27

1.2

108.83

112.29

1.31

266

850

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

211

597

1.86

14.18

1.2

362.49

309.71

pmol/l

0.29

148

442

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

475

1666

1.50

14.15

1.1

1.02

1.05

u/l

0.88

196

772

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

408

1385

1.55

14.12

1.7

1.5

1721942.14

1940093.83

iu/ml

0.14

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

310

984

1.66

14.11

1.1

—

(3003694) ABO and Rh group [Type] in Blood

18542

92125

1.07

14.09

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

323

1037

1.64

14.07

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

685

2582

1.40

13.98

2.9

2.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

489

1731

1.49

13.95

1.5

1.6

6.13

6.96

u/l

0.73

376

1410

(3051593) INR in Capillary blood by Coagulation assay

354

1166

1.60

13.93

8.0

10.4

—

(4034850) Laboratory test

2163

9466

1.20

13.89

10.1

9.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

711

2702

1.38

13.84

1.6

1.8

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

449

1570

1.50

13.60

1.0

37.34

44.31

ng/l

2.62

317

1085

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

446

1558

1.51

13.57

1.0

358.59

336.79

ng/l

0.10

321

1097

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

448

1568

1.50

13.51

1.0

776.20

717.79

ng/l

1.87

310

1062

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

834

3264

1.34

13.51

1.1

98.61

94.42

4.18

785

3054

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

973

3897

1.31

13.46

1.7

1.8

2753.33

3920.00

titre

0.33

170

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1485

6273

1.25

13.44

1.5

1.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

490

1757

1.47

13.15

1.0

0.51

1.01

u/ml

0.72

121

465

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

340

1126

1.59

13.12

1.6

1.9

29.21

28.58

umol/l

0.56

326

1088

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2596

11609

1.18

13.11

5.3

4.9

1.77

1.68

3.09

2444

10858

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

754

5279

0.75

13.09

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

298

958

1.63

12.97

1.1

1.0

9.62

12.68

u/ml

1.32

164

558

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2023

8888

1.20

12.50

2.4

2.7

181.59

186.09

1.41

1907

8426

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

312

1028

1.59

12.34

2.5

2.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

313

1034

1.59

12.25

2.3

2.4

133.43

155.91

nmol/l

3.46

278

879

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

517

1900

1.43

12.24

1.2

1.1

1.06

1.07

ratio

0.96

207

641

(3020874) Milk IgE Ab [Units/volume] in Serum

542

2013

1.42

12.12

1.0

1.1

4.25

1.62

u/ml

0.81

176

685

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

813

3229

1.32

11.99

1.1

1.2

—

(3017509) Phencyclidine [Presence] in Urine

140

365

2.01

11.97

2.1

1.7

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

803

3195

1.32

11.71

2.4

2.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

529

1972

1.41

11.61

1.0

1.1

2.44

2.79

u/ml

0.14

124

524

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

202

603

1.76

11.55

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2534

11435

1.17

11.49

5.4

4.9

0.90

0.00

2385

10689

(3044242) Glucose [Moles/volume] in Arterial blood

349

1201

1.53

11.48

2.1

1.9

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

402

1426

1.48

11.46

2.3

201.33

203.66

u/l

0.21

397

1418

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

329

1121

1.54

11.33

1.8

2.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1122

4689

1.26

11.24

2.1

3.79

6.98

titre

0.92

137

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2178

9729

1.18

11.20

2.1

2.5

94.31

91.81

5.93

2078

9332

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

512

1912

1.41

11.15

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.56

11.10

2.5

1.8

2.32

2.36

mu/l

0.02

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.36

11.10

1.3

1.4

536.30

501.54

nmol/l

0.13

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

520

1951

1.40

11.03

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

517

1943

1.40

10.87

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

559

2130

1.38

10.84

2.8

2.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

381

1356

1.48

10.73

1.1

97.46

96.52

0.22

299

1080

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

397

1428

1.46

10.61

1.9

139.66

141.57

0.18

371

1350

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

133

2.64

10.54

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

180

535

1.77

10.50

1.2

1.3

60.91

85.08

mu/l

0.70

131

402

(3015183) Erythrocyte sedimentation rate

424

1548

1.44

10.49

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

321

1108

1.52

10.47

1.8

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

321

1109

1.52

10.43

1.8

2.1

—

(40762365) Oxygen content in Arterial blood by calculation

147

411

1.88

10.40

2.7

3.0

15.13

14.71

ml/dl

0.84

136

381

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1405

6075

1.22

10.34

1.4

1.5

106.69

112.50

u/ml

1.05

374

1293

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

134

365

1.93

10.24

1.1

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

687

2728

1.32

10.24

3.9

4.9

106.15

118.61

u/ml

0.17

206

886

(3000093) Morphology [Interpretation] in Blood Narrative

682

2711

1.32

10.10

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

399

1452

1.44

10.07

2.1

2.2

22.29

42.55

umol/l

2.08

144

(3006922) Hepatitis E virus Ab [Presence] in Serum

552

2126

1.37

10.07

1.1

—

(3024263) Appearance of Synovial fluid

388

1405

1.45

10.05

1.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

208

2.25

10.05

2.1

2.0

1.30

1.29

umol/l

0.09

184

(3017817) Protein [Mass] in Urine collected for unspecified duration

643

2537

1.33

10.03

2.3

2.5

0.95

0.44

—

(3023420) DNA double strand Ab [Units/volume] in Serum

811

3305

1.29

10.02

1.5

1.6

27.59

34.69

iu/ml

0.89

156

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

468

1758

1.40

9.93

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

475

1791

1.39

9.86

1.3

1.4

—

(3016038) Potassium [Moles/volume] in Urine

460

1725

1.40

9.86

1.3

1.2

32.22

34.68

mmol/l

1.52

389

1495

(3036603) Volume of Urine

489

1856

1.38

9.77

1.5

1.6

2016.77

1945.50

0.85

476

1802

(21494890) Protein electrophoresis panel - 24 hour Urine

676

2709

1.31

9.49

1.8

2.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

201

638

1.65

9.35

1.1

53.17

63.95

u/ml

1.36

196

623

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

547

2133

1.35

9.27

1.4

12.17

12.07

umol/l

0.11

516

2023

(42529582) MDA5 Ab [Presence] in Serum by Line blot

204

652

1.64

9.25

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

204

652

1.64

9.25

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

204

652

1.64

9.25

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

204

652

1.64

9.25

1.1

—

(3022689) Creatine [Moles/volume] in Urine

231

762

1.59

9.24

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

222

726

1.61

9.20

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

117

317

1.94

9.13

1.0

0.24

0.20

u/ml

0.10

203

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

207

2.18

9.11

1.0

0.37

1.13

u/ml

0.79

140

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

290

1011

1.51

9.11

1.1

94.20

90.18

1.38

132

486

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

193

612

1.66

9.03

1.5

1.6

0.39

0.40

ug/l

0.28

123

403

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

293

1028

1.50

8.94

1.2

1.1

112.38

107.80

1.05

256

939

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

154

460

1.76

8.92

1.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

209

681

1.61

8.82

1.4

1.3

16.90

16.83

umol/l

0.07

190

606

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1604

7135

1.18

8.77

1.3

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

282

987

1.50

8.72

1.1

97.78

90.24

2.41

133

476

(3026470) Cobalt [Mass/volume] in Blood

410

1542

1.40

8.71

1.9

2.0

3.41

3.88

ug/l

0.66

376

1413

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

229

2.09

8.68

1.7

1.6

1.99

1.91

mg/l

0.05

142

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

223

2.10

8.58

1.7

1.6

2.24

2.53

mg/l

0.23

151

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

223

2.10

8.58

1.7

1.6

3.78

3.43

mg/l

0.17

132

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

223

2.10

8.58

1.7

1.6

0.80

1.01

mg/l

0.29

143

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

223

2.10

8.58

1.7

1.6

1.95

2.16

mg/l

0.11

140

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

223

2.10

8.58

1.7

1.6

2.32

1.93

mg/l

0.25

157

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

223

2.10

8.58

1.7

1.6

1.68

1.90

mg/l

0.23

160

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

223

2.10

8.58

1.7

1.6

2.09

2.87

mg/l

0.59

155

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

223

2.10

8.58

1.7

1.6

1.81

1.95

mg/l

0.08

134

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

223

2.10

8.58

1.7

1.6

1.02

1.43

mg/l

0.37

131

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

348

1277

1.43

8.50

2.2

2.1

89.03

106.29

ug/min

0.19

306

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

226

758

1.57

8.48

1.6

9.65

8.77

ug/l

1.89

226

758

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

335

1221

1.44

8.48

2.3

2.5

53.33

51.49

umol/l

0.44

286

1055

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

238

808

1.55

8.48

2.7

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

238

808

1.55

8.48

2.7

2.5

—

(3013466) aPTT in Blood by Coagulation assay

166

2.28

8.46

1.1

36.06

37.53

0.72

144

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

481

1867

1.35

8.45

2.6

3.5

95.28

139.13

nmol/l

2.65

469

1834

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

205

673

1.60

8.42

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

322

1170

1.45

8.30

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

179

570

1.65

8.29

1.2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

223

2.07

8.27

1.2

42.84

50.09

mg/l

0.98

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

206

681

1.59

8.23

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.03

8.22

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

114

319

1.88

8.16

1.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

450

1739

1.36

8.15

1.2

83.82

92.93

u/l

1.14

386

1537

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

216

725

1.56

8.11

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

439

1692

1.36

8.09

1.2

23.88

24.53

u/l

0.10

369

1475

(43055442) Apixaban [Mass/volume] in Serum or Plasma

111

310

1.88

8.00

1.6

107.60

115.02

ug/l

0.30

256

(21494755) Public health laboratory ask at order entry panel

7047

34428

1.08

7.96

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1464

6520

1.18

7.94

1.8

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

217

733

1.55

7.94

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1440

6405

1.18

7.93

3.9

3.1

25.17

27.08

mg/l

1.07

850

4100

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

151

2.29

7.91

1.2

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

766

3198

1.26

7.91

2.8

3.4

6.16

7.74

nmol/l

0.37

742

3103

(40762814) Titanium [Mass/volume] in Blood

135

403

1.76

7.90

2.2

2.3

5.00

3.43

ug/l

0.85

143

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

258

908

1.49

7.83

2.4

3.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

225

769

1.54

7.82

1.2

39.86

40.02

g/l

0.05

111

430

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

410

1578

1.37

7.65

2.1

2.5

794.17

1113.70

u/ml

2.60

404

1559

(3028717) Thiamine [Mass/volume] in Blood

256

1.95

7.62

1.2

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

171

551

1.63

7.62

1.3

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

378

1437

1.38

7.61

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

393

1504

1.37

7.60

2.0

2.1

2.09

2.43

ug/l

1.28

315

1275

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

400

1536

1.37

7.58

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

606

2474

1.29

7.53

1.2

192.17

183.22

titre

0.09

422

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

216

739

1.54

7.50

1.1

—

(3010503) CD19 cells [#/volume] in Blood

455

1789

1.34

7.42

2.2

2.7

0.35

0.31

e9/l

0.12

440

1747

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2665

12460

1.13

7.38

2.0

1.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

117

342

1.80

7.37

1.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

603

2469

1.28

7.34

1.2

228.42

184.64

titre

0.19

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

115

337

1.79

7.20

1.9

2.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.23

7.11

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

188

632

1.56

7.08

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

122

366

1.75

7.08

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

374

1438

1.37

7.07

1.2

1.1

4.28

4.11

iu/ml

0.09

123

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

282

1.86

7.06

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

130

398

1.72

7.03

1.7

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

430

1691

1.34

7.03

1.2

—

(3016750) Collection duration of Urine

412

1613

1.34

6.95

2.1

2.2

497.99

501.52

min

0.31

289

1234

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

575

2359

1.28

6.92

1.2

—

(3045716) Anion gap in Serum or Plasma

326

1230

1.39

6.92

2.7

2.3

9.57

9.87

mmol/l

0.83

317

1193

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

574

2355

1.28

6.91

1.2

—

(3006462) Nitrate [Presence] in Urine

371

1431

1.36

6.89

3.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

574

2357

1.28

6.87

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

872

3756

1.22

6.85

6.5

6.2

11.36

11.51

mg/l

0.39

795

3446

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

164

539

1.60

6.81

5.2

6.3

67.56

71.12

0.91

128

427

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

267

975

1.44

6.80

1.0

—

(3011412) CD3 cells [#/volume] in Blood

701

2952

1.25

6.80

2.1

2.5

1.30

1.19

e9/l

1.57

628

2637

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

6230

30481

1.08

6.78

1.7

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

523

2127

1.29

6.75

2.1

2.6

551.50

526.18

e6/l

0.36

439

1777

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

438

2999

0.76

6.74

1.4

1.5

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

171

2.09

6.61

1.0

23.75

18.07

u/ml

0.34

142

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

285

1.82

6.60

2.0

2.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1125

4987

1.19

6.54

1.6

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

283

1055

1.41

6.47

2.0

1.9

154.79

166.28

1.13

260

1004

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

522

2136

1.28

6.45

1.7

1.9

3.71

3.80

mg/l

0.19

487

2040

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

566

2340

1.27

6.45

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

101

295

1.80

6.44

1.0

0.25

0.54

u/ml

0.71

178

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

306

1158

1.39

6.42

1.1

818.19

427.38

ng/l

0.30

268

(40759836) Histone Ab [Presence] in Serum by Immunoblot

565

2337

1.27

6.41

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

188

650

1.52

6.31

1.0

1.1

4.66

1.33

u/ml

0.45

150

562

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2017

9368

1.13

6.29

2.4

2.7

3.69

3.57

g/l

2.58

1905

8945

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

565

2344

1.27

6.27

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

404

1608

1.32

6.15

1.7

2.93

2.37

u/field

0.67

305

1132

(3004775) Volume in Urine collected for unspecified duration

532

2198

1.27

6.12

2.1

2.3

665.24

674.72

0.19

350

1536

(3012494) Peanut IgE Ab [Units/volume] in Serum

257

952

1.42

6.12

1.1

10.44

8.69

u/ml

0.06

143

545

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

127

403

1.65

6.10

1.4

161171.64

193928.61

nmol/l

0.09

103

329

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

504

2071

1.28

6.06

2.1

2.7

0.25

0.23

e9/l

1.14

436

1780

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

156

2.09

6.05

1.2

1.1

1.05

1.20

u/field

0.78

104

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

259

1.82

6.04

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1376

6243

1.16

6.04

5.0

5.9

4631.83

1078.23

iu/ml

0.50

179

931

(3028433) Virus identified in Specimen by Culture

257

955

1.41

6.02

1.1

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

121

381

1.67

5.99

1.1

1.3

34.50

44.52

mg/l

1.79

101

327

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

166

566

1.54

5.96

1.1

6.64

7.05

u/ml

0.02

104

419

(3039000) Anion gap in Blood

1407

6401

1.16

5.96

7.1

6.6

11.38

11.19

mmol/l

1.25

1284

5739

(3018572) Chloride [Moles/volume] in Blood

1407

6402

1.16

5.95

7.1

6.6

104.86

105.20

mmol/l

1.80

1284

5741

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3303

15842

1.10

5.77

2.6

3.4

40.43

54.01

u/ml

1.79

3185

15305

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

273

1034

1.39

5.76

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

208

1.89

5.66

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

133

437

1.60

5.62

1.8

66.43

55.18

pmol/l

0.30

102

379

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

504

2093

1.27

5.61

1.1

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

102

315

1.70

5.46

1.0

1.1

1.83

1.91

u/ml

0.02

237

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

104

323

1.69

5.46

1.0

0.03

0.65

u/ml

1.96

189

(3024869) Neuronal Ab [Presence] in Serum

142

478

1.56

5.44

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

118

380

1.63

5.41

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

126

413

1.60

5.39

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

101

313

1.69

5.35

1.0

1.1

0.54

2.07

u/ml

1.83

241

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

266

1017

1.37

5.34

2.8

3.0

28.00

28.77

umol/l

0.45

193

778

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

712

3089

1.21

5.33

1.3

1.4

8.60

7.98

mmol/l

3.37

690

2981

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

470

1949

1.27

5.32

1.4

12.40

12.72

u/l

0.49

452

1883

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

302

1180

1.34

5.29

2.5

2.6

110.33

166.10

au/ml

1.36

155

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

150

515

1.53

5.28

1.2

1.5

5.11

5.92

nmol/l

1.87

138

499

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

137

461

1.56

5.27

1.5

1.4

0.23

0.25

nmol/l

0.32

331

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

430

1767

1.28

5.24

1.3

1.4

5.73

5.54

mmol/l

2.52

403

1677

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

110

351

1.65

5.24

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

105

331

1.67

5.24

1.0

0.09

3.44

u/ml

1.24

191

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1050

4722

1.17

5.24

2.6

3.0

12066.62

4357.94

u/ml

0.35

269

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

140

475

1.55

5.20

2.4

2.7

57.90

48.38

mg/l

0.15

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

207

762

1.43

5.18

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1765

10383

0.89

5.15

1.5

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

178

639

1.46

5.09

1.9

—

(21491868) Cryoglobulin [Mass/volume] in Serum

261

1004

1.37

5.07

1.1

1.2

0.31

0.52

g/l

0.60

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

117

383

1.60

5.06

1.2

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

108

2.19

4.99

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

370

1502

1.29

4.99

1.1

1524.09

1509.22

miu/ml

0.09

370

1502

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

469

1961

1.26

4.99

1.7

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

129

435

1.56

4.95

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

317

1262

1.32

4.93

4.3

4.9

4190.04

1715.53

mg/l

0.81

211

910

(3039744) RNA polymerase III Ab [Units/volume] in Serum

242

1.76

4.91

1.0

7.89

3.24

u/ml

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

200

1.84

4.89

1.0

12.77

7.41

u/ml

0.83

144

(3019174) dRVVT (LA screen)

266

1.72

4.88

1.1

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

237

905

1.38

4.84

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

694

3035

1.20

4.83

3.1

3.3

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.78

4.82

1.8

1.3

263.14

322.35

nmol/l

0.20

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

263

1023

1.35

4.79

2.2

2.0

65.61

59.40

ug/l

0.48

257

999

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

135

464

1.53

4.78

1.2

1.4

73.55

289.21

ng/l

0.64

300

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

199

1.82

4.70

1.0

0.56

2.13

u/ml

1.15

159

(3011325) HIV 1+2 Ab [Presence] in Serum

136

2.01

4.69

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.78

4.67

6.2

5.0

0.25

0.21

mmol/l

0.30

(3028679) Herpes simplex virus Ab [Presence] in Serum

428

1788

1.26

4.62

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

3001

14494

1.09

4.58

3.5

3.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

135

470

1.51

4.53

1.2

1.3

58.33

168.39

titre

1.08

(3029075) Extractable nuclear Ab panel - Serum

233

899

1.36

4.50

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.24

4.49

1.0

1.1

0.21

g/l

0.24

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

191

1.81

4.47

1.1

8.56

10.17

u/l

0.35

191

(3001556) Androgen free Index in Serum or Plasma

103

339

1.59

4.42

1.5

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

188

1.81

4.41

1.1

1.3

1.82

4.67

u/ml

0.81

159

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

247

1.70

4.38

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.43

4.35

1.1

—

mmol/l

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

726

3227

1.18

4.27

1.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

219

845

1.36

4.26

1.4

50.35

55.49

1.15

183

729

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

314

1.60

4.24

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

725

3227

1.18

4.20

1.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

440

1867

1.24

4.19

1.7

2.2

98.75

97.35

0.36

393

1756

(3018001) Oat IgE Ab [Units/volume] in Serum

211

1.74

4.18

1.0

0.25

0.86

u/ml

0.66

125

(3009015) Lactate [Moles/volume] in Synovial fluid

263

1.66

4.16

1.3

4.92

6.54

mmol/l

2.09

134

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

107

362

1.55

4.12

1.4

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1014

4641

1.15

4.11

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1349

7944

0.89

4.10

1.4

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

330

1361

1.27

4.03

1.1

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1488

6988

1.12

4.03

1.4

105.67

135.04

pmol/l

2.02

1440

6818

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

119

415

1.51

4.01

4.5

4.8

49.44

45.27

ug/min

0.23

336

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

4.87

4.01

1.0

—

(3018133) Calcium [Moles/volume] in Urine

130

462

1.48

4.01

2.2

1.9

2.57

2.61

mmol/l

0.06

116

421

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

254

1013

1.32

4.00

1.9

1.6

70969.78

15098.20

u/ml

0.66

129

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

199

1.74

3.96

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

320

1.57

3.96

2.3

2.5

1.11

1.27

mmol/l

0.25

226

(3051339) Copper [Moles/volume] in Blood

138

1.90

3.95

1.2

1.3

16.70

16.50

umol/l

0.10

118

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.62

3.93

1.4

128.00

112.03

nmol/l

0.22

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

325

1.57

3.92

1.1

—

(3012898) Urea [Moles/volume] in Urine

277

1.61

3.85

1.5

1.6

186.38

153.36

mmol/l

1.39

246

(3027035) Albumin [Mass/time] in 24 hour Urine

241

1.66

3.83

1.4

1.2

163.29

305.06

mg/24h

0.39

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

233

926

1.32

3.78

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

4186

20638

1.07

3.78

1.4

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

175

1.77

3.76

1.4

1.3

22.12

15.35

pmol/l

0.61

151

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

309

1.56

3.70

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

138

1.86

3.67

1.0

0.55

10.63

u/ml

0.49

(3017704) Immunofixation for Urine

343

1443

1.25

3.60

1.6

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

2.85

3.59

1.1

1.4

194.28

161.96

nmol/l

0.20

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

313

1303

1.26

3.59

3.2

3.1

7.59

8.13

mg/l

0.77

239

1053

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

160

605

1.39

3.59

1.1

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

166

1180

0.74

3.57

2.7

3.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

160

606

1.39

3.56

1.1

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

208

823

1.33

3.51

1.8

1.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

280

1.57

3.51

1.1

1.88

2.96

umol/24h

0.39

280

(3025130) Human papilloma virus identified in Specimen

998

4620

1.14

3.49

1.7

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.26

3.44

1.7

1.4

225.38

298.48

nmol/l

0.34

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

159

606

1.38

3.42

1.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

152

575

1.39

3.42

1.5

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1805

10350

0.91

3.36

2.8

3.6

808.89

2077.38

u/ml

1.03

1518

8915

(3042301) Urate [Moles/volume] in Synovial fluid

2.51

3.35

1.0

389.45

334.97

umol/l

0.49

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

168

649

1.36

3.34

1.1

94.18

85.64

1.37

179

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

141

530

1.40

3.31

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.02

3.30

2.1

2.0

—

(36303858) Crystals [Presence] in Urine

2.69

3.29

1.1

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.88

3.28

1.0

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.41

3.25

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

216

1.63

3.23

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

304

1280

1.25

3.21

1.9

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

174

681

1.34

3.20

1.1

1.3

110.02

107.39

0.46

162

647

(3034274) Bile acid [Moles/volume] in Serum --fasting

1073

5021

1.12

3.19

1.8

2.2

5.62

6.94

umol/l

2.30

793

3671

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.24

3.15

1.8

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

803

4792

0.88

3.14

3.1

3.7

36.19

38.84

u/ml

0.14

777

4628

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

122

452

1.42

3.13

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

158

1.73

3.12

1.0

1.1

0.57

11.90

u/ml

0.49

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

158

1.73

3.12

1.5

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

323

1.50

3.10

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

353

1.47

3.10

1.3

1.4

148.00

154.45

titre

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.06

3.10

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

315

1.50

3.08

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

131

493

1.39

3.08

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

532

3263

0.85

3.07

1.5

1.6

7.96

7.59

mmol/l

3.24

513

3126

(3051651) Icteric interference index of Serum or Plasma

407

1779

1.20

3.03

3.5

3.9

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

165

647

1.34

3.02

1.1

76.12

74.72

0.11

172

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.32

3.02

1.2

1.4

61.25

54.50

e6/l

0.05

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

250

1.55

2.98

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

110

1.86

2.97

1.2

1.3

1.04

1.18

u/field

0.40

(3016273) Islet cell 512 Ab [Units/volume] in Serum

214

1.59

2.92

1.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

217

891

1.28

2.88

1.7

137.89

138.29

au/ml

0.00

118

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

107

394

1.43

2.87

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

283

1.50

2.83

1.1

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

233

1.55

2.81

1.5

1.3

8.37

14.87

pmol/l

1.48

202

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

266

1124

1.24

2.79

1.8

2.1

8.36

9.51

mg/l

2.37

206

909

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

409

1805

1.19

2.78

5.8

6.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1664

9483

0.92

2.77

1.7

1.8

—

(3041806) Other cells [#/volume] in Blood by Manual count

359

1568

1.20

2.73

1.6

1.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

114

429

1.39

2.73

1.0

0.65

0.23

u/ml

0.68

269

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

181

1.62

2.73

1.0

1.02

0.47

u/ml

0.41

165

(1175426) CD3 cells/100 lymphocytes in Blood

527

2381

1.16

2.70

1.9

2.1

73.02

72.85

0.09

506

2290

(37019676) Renin [Units/volume] in Plasma --supine

2.19

2.70

1.0

1.1

74.31

61.21

mu/l

0.12

(3048879) Bone marrow aspiration report

190

775

1.29

2.68

1.5

1.9

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

4.29

2.67

1.1

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

435

1938

1.18

2.66

1.8

1.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

144

567

1.33

2.62

1.3

1.2

78.47

40.41

mg/l

0.35

421

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

2.25

2.61

1.0

0.03

0.13

u/ml

0.56

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.25

2.61

1.1

2.95

2.33

0.34

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

222

1.54

2.55

1.2

12.52

15.57

nmol/l

0.80

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

110

417

1.38

2.55

1.4

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

210

1.55

2.53

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.62

2.52

1.4

1.0

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

109

1.78

2.52

1.2

1.1

1.82

1.00

u/field

0.47

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

120

463

1.36

2.51

1.1

2.97

7.90

pmol/l

0.62

(3042111) Morphology [Interpretation] in Bone marrow Narrative

948

4476

1.11

2.50

1.5

1.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

194

1.57

2.50

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.01

2.48

1.1

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.82

2.48

1.1

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

941

4444

1.11

2.47

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

137

0.38

2.47

3.4

3.1

—

(3027874) Urate [Moles/volume] in Urine

1.90

2.47

1.0

1.1

1.82

9.24

mmol/l

0.49

(3036071) Salmonella sp Ab [Titer] in Serum

236

1000

1.24

2.46

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

235

996

1.24

2.45

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

225

1.52

2.42

1.0

1.1

0.40

0.80

u/ml

1.27

139

(3020123) Porphyrins [Interpretation] in Serum or Plasma

163

1.61

2.40

1.1

1.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

515

2350

1.15

2.37

1.9

2.1

14.66

14.99

0.30

504

2283

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.83

2.36

1.1

1.2

1807.21

3808.09

ng/l

0.98

(3016228) CD19 cells/100 cells in Blood

278

1205

1.21

2.35

2.0

2.1

9.56

8.23

0.86

268

1180

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

160

1.61

2.34

1.1

47.11

97.89

u/l

0.64

126

(3006576) Bicarbonate [Moles/volume] in Blood

231

983

1.23

2.34

5.7

6.4

25.11

24.98

mmol/l

0.19

218

882

(3011335) Digoxin [Mass/volume] in Serum or Plasma

199

1.53

2.27

2.6

2.3

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

204

1.52

2.24

1.2

1.1

31.53

21.16

0.49

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

130

0.40

2.22

2.5

3.1

—

(3047189) Immunofixation for 24 hour Urine

275

1202

1.20

2.17

1.7

1.8

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.86

2.15

1.1

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

149

992

0.79

2.13

3.1

3.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

275

1205

1.20

2.12

2.5

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

149

991

0.79

2.12

6.2

6.3

—

(3002619) Bacteria identified in Specimen by Culture

147

602

1.28

2.10

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.87

2.09

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

297

1841

0.85

2.09

2.5

2.8

43.20

38.80

3.57

181

992

(40768441) Liver Pathology biopsy report

474

2173

1.15

2.09

1.3

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

117

1.66

2.04

1.1

1.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

270

1.42

2.02

1.1

20.60

20.05

u/l

0.08

184

(3019768) Coxiella burnetii Ab [Presence] in Serum

171

1.53

2.02

1.2

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

101

395

1.34

2.01

1.3

53.33

52.11

0.08

197

(3046861) Legionella sp Ag [Presence] in Urine

138

1.60

2.00

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

269

1184

1.19

2.00

2.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.34

1.99

6.2

5.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

223

1.46

1.99

1.1

11.57

19.06

iu/ml

0.53

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.75

1.98

1.0

1.1

160.25

244.98

pmol/l

0.86

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

177

1.51

1.94

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.79

1.94

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

506

2344

1.13

1.94

1.9

2.0

1.97

2.40

u/field

0.97

260

998

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

479

2216

1.14

1.88

2.0

2.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

124

1.61

1.88

1.7

1.4

0.20

0.18

u/l

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

120

1.62

1.87

1.2

1.1

0.05

0.40

mg/l

0.51

109

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

337

1.35

1.87

1.8

1.7

1.59

1.74

mg/l

0.44

283

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.30

1.87

2.1

2.3

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

141

1.56

1.86

1.9

1.7

179.27

214.78

ng/l

1.73

122

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.35

1.82

1.1

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

221

965

1.20

1.82

1.5

1.4

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.90

1.80

1.0

2.92

0.39

u/ml

0.44

(3034426) Prothrombin time (PT)

239

1053

1.19

1.79

1.3

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

486

2259

1.13

1.79

2.2

2.7

802.90

665.12

e6/l

3.55

465

2191

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

168

1.50

1.78

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

147

1.54

1.78

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

318

1.35

1.76

1.1

1.3

—

(3013862) HLA-DP [Type]

131

0.48

1.75

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

118

483

1.28

1.75

1.2

1.63

1.67

mmol/l

0.10

304

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

221

1.42

1.74

1.3

1.2

97.37

109.99

ug/l

0.27

130

(3008037) Lactate [Moles/volume] in Venous blood

1259

6141

1.08

1.74

3.5

3.1

1.56

1.58

mmol/l

0.33

1221

6024

(3009871) Measles virus Ab [Titer] in Serum

235

1038

1.19

1.73

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1159

5640

1.08

1.71

2.8

3.5

400.09

904.01

u/ml

1.77

1060

5116

(40760409) HLA-A [Type] by High resolution

129

0.49

1.68

1.0

—

(40760410) HLA-B [Type] by High resolution

129

0.49

1.68

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.69

1.68

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

196

854

1.20

1.68

1.3

1.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

281

1.36

1.66

1.1

—

(40768793) Breast Pathology biopsy report

1346

6595

1.07

1.66

1.3

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

167

1.48

1.65

1.0

1.1

1.67

2.92

u/l

—

(3036782) Glucose [Moles/volume] in Pleural fluid

538

2531

1.12

1.65

1.3

6.38

6.24

mmol/l

0.48

496

2343

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

117

483

1.27

1.64

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

142

1.52

1.62

1.1

1.5

—

(3013762) Body weight Measured

134

0.51

1.62

1.0

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

383

1.30

1.61

2.8

2.6

58.78

75.20

pmol/l

0.56

330

(3033942) Copper [Moles/time] in 24 hour Urine

134

1.53

1.60

1.1

1.2

1.21

0.81

umol/24h

0.23

(4035726) Immunohistochemistry procedure

5063

25693

1.04

1.60

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

306

1.34

1.59

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

160

1.48

1.58

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

100

407

1.29

1.58

2.5

3.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

484

0.75

1.56

2.1

2.5

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

114

1.57

1.55

5.3

5.7

15.88

17.43

mmol/l

0.88

106

(3000219) Insulin receptor Ab [Presence] in Serum

3.75

1.51

1.0

—

(3008896) Cortisol [Moles/volume] in Urine

3.15

1.50

1.2

—

(46236302) HLA-C [Type] by High resolution typing

130

0.52

1.49

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

172

751

1.20

1.48

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

189

1.42

1.48

1.5

1.4

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

161

700

1.21

1.46

1.1

6.27

7.04

mg/g

0.76

153

664

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.70

1.44

1.0

0.32

0.94

u/ml

0.88

(3021661) Pineapple IgE Ab [Units/volume] in Serum

1.97

1.44

1.0

0.10

0.25

u/ml

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.97

1.44

1.1

1522.67

2183.25

titre

0.71

(40768446) Kidney Pathology biopsy report

272

1238

1.15

1.44

1.7

—

(40763590) HLA-DQ beta [Type]

128

0.53

1.43

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

121

1.52

1.43

1.4

1.2

0.06

0.07

g/l

1.15

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.60

1.41

1.0

0.30

0.19

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

209

1.38

1.40

1.1

17.43

23.62

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

209

1.38

1.40

1.1

18.84

30.07

u/ml

0.75

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.62

1.40

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

187

1.40

1.39

1.3

1.4

294.72

324.99

umol/24h

0.61

187

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

241

1.35

1.38

1.3

1.05

1.55

ml/s/173m2

0.74

156

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.86

1.37

1.0

1.1

18.67

14.73

umol/l

—

(3042628) Porphyrins [Moles/volume] in Urine

2.86

1.37

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

171

753

1.19

1.37

1.3

37.85

38.28

0.05

120

508

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

210

1.37

3.1

3.0

8.74

424.93

pmol/l

0.67

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

446

2104

1.11

1.36

1.8

1.9

—

(3022475) Manganese [Moles/volume] in Blood

188

1.40

1.36

1.3

—

(21494434) Karyotype in Bone marrow

501

2379

1.11

1.35

1.2

—

(3045142) Bone marrow Pathology biopsy report

635

3050

1.09

1.35

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

175

1.41

1.35

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

154

1.43

1.31

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

185

1.39

1.31

1.4

—

(40765096) Chromosome analysis panel by Banding

179

797

1.18

1.29

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

105

444

1.24

1.28

1.1

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

410

1935

1.11

1.27

1.3

13.76

14.27

u/l

0.18

379

1785

(3015350) Toxocara sp Ab [Presence] in Serum

2.03

1.26

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

2.03

1.26

1.0

—

0.05

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

2.62

1.26

1.2

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

2.62

1.26

1.2

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

395

0.76

1.25

7.7

9.1

0.35

0.40

umol/l

0.31

360

(3036048) Francisella tularensis Ab [Titer] in Serum

162

718

1.18

1.24

1.2

352.00

584.24

titre

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

139

1.43

1.22

1.4

1.3

1.81

1.53

mg/l

0.95

119

(3045177) Copper [Moles/volume] in Urine

1.83

1.21

1.0

1.1

0.37

0.46

umol/l

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

1.64

1.21

1.2

1.0

1.19

1.37

u/field

0.25

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

222

0.69

1.18

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

252

0.71

1.16

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

154

1.40

1.16

1.4

1.8

0.69

0.71

umol/l

0.11

120

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

217

1.33

1.16

2.7

2.5

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

143

632

1.19

1.15

1.4

24.32

22.93

0.22

120

522

(3041354) Potassium [Moles/volume] in Venous blood

710

3457

1.08

1.14

2.5

2.3

4.03

4.06

mmol/l

0.96

704

3430

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.45

1.14

1.1

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.72

1.13

1.1

—

(4281824) Cell count and differential, peritoneal fluid

561

3194

0.92

1.11

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

709

3457

1.08

1.11

2.5

2.3

105.96

105.61

mmol/l

1.28

703

3429

(40763791) Oxygen content in Venous blood by calculation

1.58

1.11

3.9

7.7

12.28

12.26

ml/dl

0.01

(3051101) Glucose [Moles/volume] in Cord blood

510

0.80

1.10

5.0

5.8

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

363

1.24

1.10

1.1

1.6

9.52

72.06

u/ml

—

(40762887) Creatinine [Moles/volume] in Blood

1.66

1.08

1.2

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

1168

5797

1.06

1.08

3.6

3.2

7.42

7.58

mmol/l

0.91

1137

5699

(3026480) Teichoate Ab [Titer] in Serum

239

1.30

1.06

1.1

—

2.67

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

440

2110

1.09

1.05

1.2

—

(3012441) Differential panel - Pleural fluid

575

2790

1.08

1.04

1.5

—

(3006598) pH of Arterial cord blood

208

0.71

1.00

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

114

502

1.19

0.99

1.4

1.3

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

173

1.33

0.98

1.1

1.2

—

470.00

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.52

0.96

1.0

0.16

0.06

u/ml

0.37

(3004959) Base excess in Arterial cord blood by calculation

206

0.71

0.96

1.0

-0.98

-2.09

mmol/l

—

(4212803) Bone marrow aspirate examination

234

1.28

0.95

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

188

1.31

0.94

1.9

1.8

0.89

0.54

0.51

145

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

188

1.31

0.94

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

204

945

1.13

0.94

2.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.25

0.93

1.3

1.1

26.45

28.14

nmol/24h

—

(40768800) Prostate Pathology biopsy report

1037

5158

1.06

0.93

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

130

1.37

0.91

1.0

0.10

0.14

u/ml

0.14

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

335

1.22

0.90

1.3

880.14

79.23

u/l

0.80

239

(3028308) Erythrocytes [#/volume] in Pleural fluid

603

2953

1.07

0.90

1.5

1.4

89243.36

46532.47

e6/l

1.59

351

1767

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

564

2756

1.07

0.89

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

364

1.21

0.89

2.9

3.2

38.77

41.71

umol/l

0.59

306

(3033705) Calcium.ionized [Moles/volume] in Venous blood

692

3406

1.07

0.89

2.5

2.3

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

2.10

0.88

1.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

2.10

0.88

1.0

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.75

0.88

1.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.75

0.88

1.1

—

(3001729) Color of Synovial fluid

223

1.27

0.87

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

256

1.25

0.87

1.2

1.1

—

(3003577) Lead [Moles/volume] in Blood

228

1.27

0.87

1.4

0.19

0.20

umol/l

0.06

(3004446) Plasmodium sp identified in Blood by Light microscopy

351

1.21

0.87

2.2

2.7

—

(3013293) Extractable nuclear Ab [Presence] in Serum

103

457

1.18

0.86

1.4

1.7

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

134

0.67

0.86

1.0

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

734

3626

1.06

0.85

1.5

1.4

33.34

32.93

g/l

0.38

664

3258

(3006245) CD3-CD19+ cells/100 cells in Blood

262

1241

1.11

0.85

2.0

2.3

9.63

10.65

0.87

247

1152

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.58

0.84

1.5

1.3

0.50

0.67

u/field

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1053

5260

1.05

0.83

1.3

3.48

3.68

ug/l

0.33

949

4756

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

224

0.75

0.83

1.6

2.6

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

160

1.31

0.83

1.4

1.23

1.45

0.15

108

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

406

1.19

0.82

1.4

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

557

2733

1.07

0.81

2.0

2.2

40.97

38.15

4.35

542

2687

(3041184) Isoniazid [Presence] in Urine

1.75

0.81

1.6

2.8

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

147

1.32

0.81

1.1

—

(3024316) Viscosity of Plasma

138

1.33

0.80

1.6

1.8

1.76

1.63

mpas

0.34

(3032743) Legionella sp IgG Ab [Presence] in Serum

203

1.27

0.79

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.60

0.77

1.1

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.60

0.77

1.0

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

254

1210

1.10

0.76

1.8

2.2

27.76

29.92

1.71

244

1143

(3022229) Phosphate [Moles/volume] in Urine

167

1.29

0.76

2.5

1.9

16.44

19.93

mmol/l

0.98

142

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

376

1.19

0.76

1.6

—

(3022670) pH of Venous cord blood

1.46

0.76

1.1

1.0

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.46

0.76

1.0

0.02

0.23

u/ml

0.79

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.69

0.75

1.1

1.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.66

0.75

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.66

0.75

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.66

0.75

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.66

0.75

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.66

0.75

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.66

0.75

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.43

0.75

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

501

2459

1.07

0.74

1.3

500.00

488.83

u/l

0.03

471

2330

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.70

0.74

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

659

3265

1.06

0.73

1.5

1.4

2681.45

3350.66

e6/l

0.52

468

2371

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

254

0.78

0.73

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

457

2565

0.93

0.72

1.6

1.8

—

(36304079) Mucus [Presence] in Urine sediment

2.02

0.72

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

195

921

1.11

0.71

1.9

2.2

236.32

717.96

e6/l

1.04

106

491

(21494567) Legionella sp IgM Ab [Presence] in Serum

212

1.24

0.69

1.1

—

(40758292) HTLV I+II Ab panel - Serum

549

0.86

0.69

1.3

1.4

—

(3009677) Dengue virus Ab [Presence] in Serum

128

1.31

0.69

1.2

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

217

1.23

0.69

5.1

5.7

—

(40768795) Lymph node Pathology biopsy report

586

2901

1.06

0.69

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

170

1.27

0.68

4.8

5.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

284

1.20

0.68

1.5

1.6

—

(40768806) Pleura Pathology biopsy report

566

2801

1.06

0.68

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

102

0.67

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.67

0.67

1.6

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

114

523

1.14

0.67

1.1

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

1.46

0.67

3.6

1.6

853.40

2186.63

umol/l

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.42

0.66

9.4

8.4

51.00

43.58

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.39

0.66

10.9

7.8

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

131

608

1.13

0.66

1.5

1.3

26.02

38.17

g/l

0.65

101

468

(3052592) Norovirus Ag [Presence] in Stool

102

613

0.87

0.65

1.2

1.3

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.75

0.65

1.1

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

186

1.24

0.64

1.0

1.3

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.64

0.0

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

423

1.15

0.63

1.1

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

316

1.18

0.63

1.3

1.2

21.62

20.69

mmol/l

0.93

264

(3007919) Fasciola sp Ab [Titer] in Serum

1.50

0.62

1.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.50

0.62

1.1

1.2

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

216

1.21

0.61

1.4

1.5

32.56

38.16

0.42

148

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

298

1.18

0.60

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

279

1.18

0.60

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

507

2813

0.95

0.59

3.2

3.9

29.84

53.44

u/ml

4.87

500

2781

(3001218) Citrate [Mass/time] in 24 hour Urine

1.54

0.59

1.6

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.36

0.59

3.1

3.3

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

180

859

1.10

0.58

1.6

1.7

530.20

33000245.20

iu/ml

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.36

0.57

1.5

1.6

164.73

115.66

ug/l

0.34

(3008536) Aspergillus sp Ab [Presence] in Serum

122

571

1.12

0.56

1.6

2.4

—

(3028468) Fragments [Presence] in Blood by Light microscopy

1.66

0.56

3.5

1.7

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.52

0.56

1.1

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

249

1410

0.93

0.55

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

222

1073

1.09

0.55

5.0

4.9

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.31

0.54

1.0

5.58

5.05

mmol/l

0.40

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

124

1.27

0.54

17.3

11.7

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

1.57

0.54

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

115

1.28

0.53

1.4

1.2

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

115

1.28

0.53

1.0

0.01

0.07

u/ml

1.24

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

144

685

1.10

0.51

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

410

0.87

0.50

7.2

6.8

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

823

4155

1.04

0.50

2.8

203.68

768.97

u/ml

1.24

814

4102

(3018291) Platelet Ab [Presence] in Serum

1.41

0.49

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.48

0.47

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.38

0.47

2.3

2.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

209

1.18

0.46

5.1

4.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

251

1407

0.94

0.46

1.2

1.3

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.67

0.45

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

282

1392

1.06

0.44

3.2

3.3

—

(40759632) Porphyrins [Mass/mass] in Stool

1.45

0.44

1.0

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

191

1.18

0.43

1.5

14.97

12.56

0.23

140

(3020399) Glucose [Mass/volume] in Urine

0.00

0.43

0.0

1.6

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.43

0.0

4.7

—

139.44

—

(40757373) Influenza virus identified in Isolate

102

592

0.90

0.43

1.9

1.4

—

(3044007) Cell count panel - Peritoneal fluid

143

816

0.92

0.42

2.1

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

270

1333

1.06

0.42

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.68

0.41

13.0

3.3

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.35

0.41

1.0

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

1.31

0.41

1.5

1.3

—

(3007733) Chloride [Moles/volume] in Urine

1.29

0.40

1.1

1.7

90.31

86.43

mmol/l

0.17

(3038071) Oxygen [Partial pressure] in Mixed venous blood

127

612

1.09

0.39

9.2

8.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.24

0.38

1.0

0.08

0.16

u/ml

0.34

(3044316) Mercury [Moles/volume] in Urine

0.61

0.37

1.6

2.6

4.52

12.35

nmol/l

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.28

0.37

5.6

5.0

5.92

6.31

mg/l

0.07

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

673

3414

1.03

0.36

1.8

1.9

22.97

25.26

ug/l

0.24

653

3345

(3023383) Lactate [Moles/volume] in Pleural fluid

167

818

1.07

0.35

1.3

3.95

3.44

mmol/l

1.08

152

750

(3010937) Rubella virus Ab [Presence] in Serum

220

0.86

0.35

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

100

573

0.92

0.35

4.9

5.6

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

1.37

0.35

1.5

1.6

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

196

1.15

0.34

1.0

1.1

1.39

1.19

u/ml

0.07

138

(1617658) Protocol used for examination of sentinel lymph nodes

399

2183

0.96

0.34

1.0

—

(40758358) Immune stain study

128

1.19

0.33

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

141

689

1.07

0.33

1.4

14.57

13.31

g/l

0.77

107

515

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

1.41

0.33

8.3

1.4

65.26

61.58

nmol/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

257

1281

1.05

0.32

1.1

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

400

0.90

0.32

1.2

1.9

6.50

7.51

mmol/l

1.84

144

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

133

0.83

0.31

8.6

9.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

343

0.90

0.29

5.7

7.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

321

0.90

0.29

1.8

2.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

130

1.17

0.29

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

101

1.19

0.29

1.1

237.14

278.72

nmol/l

0.56

101

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

279

1530

0.96

0.29

1.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.25

0.27

1.8

1.3

1.95

2.17

mmol/24h

0.28

(3006969) Lambda light chains [Mass/volume] in Urine

1.25

0.27

1.0

1.1

0.02

0.07

g/l

—

(3013727) Leukocytes other/100 leukocytes in Blood

196

977

1.05

0.27

3.7

3.5

53.10

52.14

0.24

189

943

(3035082) Kappa light chains [Mass/volume] in Urine

1.23

0.27

1.0

1.1

0.02

0.22

g/l

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

478

2430

1.03

0.27

1.4

1.5

0.98

0.94

g/l

1.68

473

2416

(3040794) Aluminum [Moles/volume] in Urine

1.24

0.26

1.3

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

377

1.09

0.26

2.6

2.4

0.63

0.59

u/field

0.11

377

(3020393) Adenovirus Ag [Presence] in Stool

357

1.09

0.26

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

143

708

1.06

0.25

1.2

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

190

949

1.05

0.25

1.6

1.5

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

339

0.91

0.25

2.6

3.1

1.39

1.22

mg/l

0.25

226

(3003157) Bacteria [#/volume] in Mother's milk

0.81

0.23

7.1

6.6

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.31

0.23

1.0

1.6

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

238

1.10

0.23

1.4

1.1

8.04

9.30

mg/l

0.31

221

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

128

634

1.06

0.23

2.3

2.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

344

1.08

0.23

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

426

1.07

0.22

2.3

1.9

—

(3020132) Chylomicrons [Presence] in Serum or Plasma

0.00

0.22

0.0

2.2

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.22

0.0

1.0

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.22

0.0

1.0

—

(3039179) Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid

0.00

0.22

0.0

1.0

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.22

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

293

1592

0.97

0.22

1.2

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

119

1.15

0.22

1.1

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.22

0.0

7.6

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

169

1.12

0.22

1.0

—

(3034614) HLA Ag [Interpretation]

1.20

0.21

1.0

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

152

837

0.95

0.21

1.4

3.02

2.72

0.17

128

702

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.31

0.21

1.2

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

150

826

0.95

0.21

1.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.26

0.21

1.0

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

470

0.94

0.20

3.0

2.7

1173.88

1783.52

u/l

0.38

426

(3000919) Neutrophils/100 leukocytes in Pleural fluid

138

760

0.95

0.20

1.4

20.55

21.75

0.21

127

684

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

198

0.90

0.20

1.1

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

137

0.88

0.19

1.0

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

333

1.07

0.19

1.4

1.3

27.37

23.65

0.37

258

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

141

707

1.05

0.18

9.0

8.1

—

(3008607) Semen analysis panel

278

1.08

0.17

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

756

3897

1.02

0.17

2.4

2.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

409

2197

0.98

0.17

16.7

18.9

1333.41

2886.68

nmol/l

1.10

391

2106

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

369

0.94

0.17

2.6

3.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

112

1.12

0.16

1.0

0.08

0.27

u/ml

0.99

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.86

0.16

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.20

0.15

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.18

0.15

1.0

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.14

0.14

2.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

706

3647

1.02

0.14

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

271

1387

1.03

0.13

26.8

27.4

115.93

117.61

ug/l

0.15

221

1160

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

246

1.07

0.13

2.9

4.3

2.28

2.27

mg/l

0.01

206

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.83

0.13

1.0

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

241

1.07

0.13

2.2

64.20

57.75

0.53

153

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

180

1.08

0.13

1.6

1.9

170.45

179.71

ug/g

0.14

158

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

165

0.92

0.12

1.4

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

283

0.95

0.11

1.3

1.2

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

110

1.10

0.11

1.0

0.06

0.49

u/ml

1.25

(3026250) Tacrolimus [Mass/volume] in Blood

275

1414

1.02

0.11

34.1

36.4

7.52

7.32

ug/l

0.96

246

1299

(3045462) Protein/Creatinine [Ratio] in Urine

308

0.95

0.10

4.3

4.6

42.58

55.73

g/mol

0.38

282

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

390

2078

0.98

0.10

12.8

13.4

781.12

1572.66

nmol/l

0.84

372

2006

(3018738) Hemoglobin F/Hemoglobin.total in Blood

227

0.95

0.09

2.0

3.1

18.30

13.60

0.42

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.09

0.09

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

111

599

0.97

0.08

1.2

—

(3024471) HLA-A [Type]

205

1096

0.98

0.08

1.0

—

(3021374) Sirolimus [Mass/volume] in Blood

0.85

0.08

7.3

10.3

7.27

7.39

ug/l

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.10

0.08

1.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

334

1.04

0.08

1.4

71.24

70.79

0.04

275

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

210

1.05

0.07

1.4

1.3

—

(3049233) Organic acids panel - Urine

1.14

0.07

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

488

2534

1.01

0.07

1.5

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

102

0.93

0.07

1.0

0.11

0.98

u/ml

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

118

1.07

0.07

1.4

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

273

1.04

0.06

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

188

1003

0.98

0.06

2.0

6501.81

2001.48

e6/l

0.53

130

674

(40765089) Chromosome analysis panel - Blood by G-banded

230

1224

0.99

0.06

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

404

0.97

0.05

1.4

10.50

10.74

0.03

194

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

272

1412

1.01

0.05

1.4

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

461

0.98

0.05

6.8

7.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

272

1413

1.01

0.04

1.4

1.5

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

376

0.98

0.04

2.5

3.0

21.86

22.99

mg/l

0.28

355

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

299

1555

1.01

0.04

5.0

6.2

880.67

3010.92

u/ml

0.53

325

(3000285) Sodium [Moles/volume] in Blood

354

0.98

0.04

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

193

1.03

0.03

2.4

2.2

14.79

16.64

0.17

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5597

29325

1.00

0.03

3.3

4.2

18.31

26.84

ug/l

1.22

4354

23624

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

187

971

1.01

0.03

1.4

61.63

62.62

0.14

151

798

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

150

796

0.99

0.03

1.6

1.9

29.90

40.65

u/l

0.46

136

718

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

168

0.97

0.02

1.2

1.3

106.69

1156.47

u/l

1.28

148

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.94

0.02

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

112

581

1.01

0.02

2.0

1.8

2.32

3.60

ug/l

0.64

361

(3035880) pH of Pleural fluid

286

1493

1.01

0.02

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

400

2093

1.00

0.01

1.3

1.4

32.01

31.69

nmol/l

0.08

359

1941

(3033799) Differential panel - Peritoneal fluid

165

861

1.01

0.01

2.0

1.8

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

170

888

1.00

0.00

2.0

1.8

13870.40

10889.57

e6/l

0.21

471

(1761482) Bacteria [#/volume] in Urine by Culture

1406

7382

1.00

0.00

4.3

4.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.98

0.00

1.0

1.1

—

(3024932) HLA-DR beta [Type]

203

1066

1.00

0.00

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

142

743

1.00

0.00

1.3

335.50

238.08

ug/l

0.21

398

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

415

2180

1.00

0.00

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

160

1.02

0.00

12.4

10.5

204.36

239.42

e6/l

0.11

117

(3014891) Appearance of Pleural fluid

380

1.01

0.00

1.4

1.3

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

149

0.99

0.00

3.1

3.5

0.00

estimate

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

407

1.01

0.00

1.2

1.3

0.94

1.39

mmol/l

0.51

262

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

182

1.01

0.00

1.1

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

135

706

1.00

0.00

2.5

2.6

99.67

107.67

ng/l

0.24

373

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

163

1.00

0.00

3.5

3.6

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.98

0.00

1.1

1.0

—

(3032641) Amino acids panel - Urine

1.02

-0.00

1.5

1.3

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

5.14

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.97

-0.00

1.0

1.3

—

(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.97

-0.00

1.0

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: SLEEP – Sleep disorders (combined)

GWS hits: 31

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Sleep disorders (combined)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints